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ABSTRACT 
Intimate partner violence (IPV) and reproductive coercion (RC) are key public health concerns 
for young women and are associated with poor sexual health outcomes. We studied 1) the 
pathways between IPV/RC and unintended pregnancy and sexually transmitted infections (STI), 
2) partner influence on use of female-controlled contraception (FCC), and 3) discordance
between self-report and medical record data for pregnancy/STI and predictors of discordance. A 
cluster-randomized controlled trial of female family planning clinic patients (ARCHES; 16-24 
years) and a nationally representative survey of women in the U.S. (NSFG survey; 15-24 years) 
were used. Women in the ARCHES study (n=2,363) self-reported IPV, RC, sexual self-efficacy, 
recent STI, past-year pregnancy, and past-year unintended pregnancy, at enrollment, four 
months, and twelve months; pregnancy and STI diagnoses were abstracted from medical records. 
Women in the NSFG survey (n=2,541) self-reported contraceptive use in the past year, whether 
they had stopped using a contraceptive method because a partner did not like it, and whether 
their partner wanted a baby but they themselves did not. 
In the ARCHES sample, sexual self-efficacy mediated the relationship between IPV/RC 
and unintended pregnancy but not IPV/RC and STI. In the NSFG sample, current use of FCC 
was low, with the majority of those on FCC using oral contraceptives. Partner influence was 
v 
associated with greater current FCC use among young adults, but adolescents both with and 
without partner influence had poorer contraceptive use. Self-report on confidential surveys and 
medical record data showed poor agreement, with self-report providing higher prevalence 
estimates compared to medical records. Women who reported recent IPV or RC, were older, or 
African-American were more likely to self-report STI and pregnancies that were not in their 
medical records. 
These findings have identified multiple pathways by which partner influence, including 
IPV and RC, impact young women’s reproductive and sexual health, thus enabling future 
interventions to target these specific points. Further, best methodologies for this research field 
were identified. Thus, this dissertation has significant public health relevance as it informs 
programs to reduce disease burden due to sexual health sequelae associated with IPV/RC, and 
improve exposure and outcome ascertainment in future research. 
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1. INTRODUCTION
1.1. BACKGROUND 
Dating, intimate, and sexual relationships have the potential for violence, coercion, and 
emotional abuse between partners. While perpetration and victimization is neither limited to one 
sex nor heterosexual relationships, the highest proportion occurs to women victimized by their 
male partners.1 This negative partner influence is a high-burden public health problem, with one 
in four women experiencing intimate partner violence (IPV)2 and 9% experiencing reproductive 
coercion (RC; attempts to control pregnancy and pregnancy outcomes of female partners)3,4 in 
their lifetimes. Adolescent and young adult women are at particular risk for victimization and 
long-term health consequences.5,6  
Evidence indicates that IPV and RC are related to poor reproductive and sexual health 
outcomes,7,8 drawing increased attention on the influence that males may have on their female 
partners’ reproductive health and contraceptive use. The focus of this project is to further the 
current understanding of how these processes occur. To accomplish this, possible mediators on 
the pathway between IPV/RC and poor reproductive health outcomes will be assessed, female 
contraceptive habits in the context of male partner influence will be characterized, and best 
methods for this area of research while considering sources of bias will be assessed.  
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The Addressing Reproductive Coercion in Health Settings (ARCHES) Study (PIs: Miller 
and Silverman; NIH grant # R01HD064407) is a cluster randomized controlled trial (RCT) to 
test the effectiveness of a clinician-delivered brief intervention on IPV and RC during routine 
clinical visits compared to standard of care in twenty four family planning clinics in Western 
Pennsylvania. The goal of the intervention is universal education and reducing risks of IPV, RC, 
and unintended pregnancies. Women ages 16-29 years receiving care at the 24 participating 
family planning clinics for any reason, speak English or Spanish, and able to give consent were 
eligible to participate. A total of 3,687 women agreed to participate. Women completed surveys 
at baseline, at a four month follow-up (T2), and a twelve month follow-up (T3). These surveys 
assessed demographics, recent and lifetime experiences of IPV, recent RC, self-efficacy (general, 
condom negotiation, use of harm reduction behaviors), recognition of sexual and reproductive 
coercion, lifetime and recent history of pregnancy, unintended pregnancy, and abortions, and for 
baseline only, future pregnancy intention. Almost all women (97%) granted us access to a total 
of 30 months of their medical record data at those clinics (one year pre-enrollment through 
eighteen months post-enrollment).  
The National Survey of Family Growth (NSFG) is a nationally representative survey of 
men and women 15-44 years of age.9 It is conducted by the Centers for Disease Control and 
Prevention’s National Center for Health Statistics. The purpose of the survey is to create 
nationally representative estimates for pregnancy and pregnancy risk, medical care associated 
with pregnancy, factors affecting household structure (e.g., marriage, divorce), adoption, father 
involvement behaviors, and attitudes about marriage, childbearing, and sex. The latest cycle was 
conducted in 2006-2010 among 12,279 women and 10,403 men.  Information self-reported by 
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women included detailed contraceptive use histories for up to the past four years, reasons for 
discontinuation of contraception, condom use frequency, and pregnancy history.  
Taken together, the ARCHES study and the NSFG are two sources of data rich in 
information on young women’s reproductive and sexual health. Advantages to the ARCHES  
study are the multiple assessments of IPV and RC over a one year period, use of a family 
planning clinic population that has higher rates of IPV and RC compared to the general 
population,7,10,11 and both self-reported and medical record data on sexual and reproductive 
health outcomes (unintended pregnancy, STI). The NSFG, on the other hand, is a nationally 
representative survey that includes a greater diversity compared to ARCHES and has extensive 
data on contraceptive use over a substantial period of time (3-4 years). Together, these data will 
allow for two differing approaches to understanding partner influence on women’s reproductive 
and sexual health.  
1.2  RESEARCH AIMS 
1)  To assess the relationship between negative male partner influence, condom use self-
efficacy, and sexual health outcomes among adolescent and young adult female clients of 
family planning clinics. We hypothesize that 1) adolescent women (16-19 years) will have 
lower levels of condom negotiation self-efficacy compared to young adult women (20-24 
years, 2) women (16-19 and 20-24 years) reporting recent experiences of intimate 
partner violence or reproductive coercion will have lower condom negotiation self-
efficacy and worse sexual health outcomes, and 3)  condom negotiation self-efficacy will 
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mediate the association between intimate partner violence/reproductive coercion and 
poor sexual health outcomes among both age groups over a one year period. 
2)  To identify differences in contraceptive use by negative partner influence over a 12 
month period in a nationally representative sample of women 15-24 years. We 
hypothesize that women who report partner influence will have 1) less current use of 
female-controlled contraceptives (FCC); 2) more months of FCC nonuse; 3) more 
changes in FCC; and 4) more FCC discontinuation in a one year period compared to 
those who have not reported partner influence. 
 
3) To assess concordance between self-report and medical record data for pregnancy and 
STI, how IPV/RC influence pregnancy and STI reporting, and how pregnancy intention 
influences reporting in adolescent and young adult female clients of family planning 
clinics. We hypothesize that 1) fewer cases of and pregnancy and STI will be recorded 
through self-report compared to medical record data; 2) those who experienced recent 
IPV or RC will have greater discordance in STI and pregnancy reporting; and 3) those 
with who did not plan to become pregnant in the next year will have greater discordance 
in STI and pregnancy reporting. 
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2. BACKGROUND AND SIGNIFICANCE 
2.1. MALE PARTNER INFLUENCE ON FEMALES 
There is increasing focus on the influence males have on their female partners. While much of 
this influence can be positive and supportive, a substantial proportion of males commit violence 
against women, including their female partners and ex-partners. For the purposes of this study, 
negative male partner influence is conceptualized as violence and coercion within dating and 
intimate relationships. The two key aspects to be covered in this project are intimate partner 
violence (IPV) and reproductive coercion (RC) (i.e., male attempts to impregnate a female 
against her wishes and to control the outcomes of a pregnancy).  
IPV – also referred to as domestic violence, domestic abuse, or, when occurring among 
teens and young adults, adolescent relationship abuse – includes physical or sexual violence or 
threats of violence, psychological and emotional abuse, and stalking by a person who is or was 
an intimate partner to the victim. Often victims experience multiple forms of abuse, such as 
physical and psychological abuse concurrently.4,12 In a sample of family planning clinic patients 
(ages 16-29), 35% of women who reported partner physical or sexual IPV also reported 
reproductive coercion, compared to 15% of women reporting RC in the absence of IPV.7  
Lifetime experience of physical violence, rape, and/or stalking at the hands of an intimate 
partner occurs in approximately 1 in 3 women (36%) in the United States4; almost half of all 
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women (48%) experience psychological aggression by intimate partners at some point in their 
lifetimes and 14% in the past 12 months.4 An estimated 10.3 million women (9%) will 
experience sexual or reproductive coercion (e.g., trying to get them pregnant when they did not 
want to be or refusing to wear a condom) in their lifetimes.4 Among high risk populations (e.g., 
family planning clinic patients), lifetime RC estimates reach 26%.7 
  Adolescents and young adult women are at considerable risk for victimization at the 
hands of their partners. Most victims (69%) of physical violence, rape, or stalking experienced 
IPV for the first time before reaching 25 years of age.4 Among 12-18 year olds, 31% of females 
had experienced psychological abuse, physical abuse, or both at the hands of a dating partner.13 
Rates are substantially higher among vulnerable populations; one study found that 45% of the 
16-20 year old patients of adolescent health clinics had been physically or sexually abused by an 
intimate partner.14 
  The negative influence of males on their female partners’ health through IPV has been an 
area of considerable research, mostly in adult women samples. Among adolescents, IPV is 
associated with depressive episodes, post-traumatic stress disorder,15 substance use, unhealthy 
weight control behaviors, suicidality,6 foregoing care in the past year, and having lower self-
rated health.8 Ever experiencing IPV (by grades 7-11) has longitudinally been associated with 
future (≥5 years) poorer self-rated health ,16 greater depressive symptoms,13,16,17 suicidal 
ideation12,13 and attempts,12 smoking,13,17 marijuana use,17 and recent low health-related quality 
of life.13  
  One of the greatest concerns when IPV occurs in adolescent relationships is a continuing 
pattern of victimization into adulthood. Strong evidence for this comes from the National 
Longitudinal Study of Adolescent Health (Add Health) in the U.S. Add Health assessed a 
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nationally representative sample of adolescents (grades 7-12 at baseline) for health behaviors and 
risk factors at three time points: Wave 1 (1994-1995), Wave 2 (1996), and Wave 3 (2001-2002; 
ages 18-25 years).13 Experiencing physical IPV as a young adult was three times as likely among 
those who experienced dating violence five years earlier (adjusted OR=2.8, 95% CI 2.1-3.8).13 
Among these IPV victims at Wave 3, almost 1 in 5 (18%) reported adolescent-young adult 
persistent victimization.18 
In addition to the negative sequelae associated with IPV, there is mounting evidence that 
some men force or influence contraceptive nonuse in an effort to exert reproductive control over 
their female partners. This phenomenon has been described as “reproductive coercion” (RC)3,7  
and is estimated to impact 9% of the adult US female population.4 RC is characterized by male 
partners’ attempts to control pregnancy and outcomes of pregnancy through birth control 
sabotage and coercion. This can include pressure to become pregnant, such as telling a partner 
not to use any birth control or threatening to leave her if she does not become pregnant. Birth 
control sabotage involves more overt actions, such as taking off the condom during sex in order 
to impregnate the woman and taking away or preventing a woman from accessing contraception. 
Post-conception, men may try to control the outcome of the pregnancy, including trying to 
prevent a woman from getting an abortion that she wants or trying to force her to get an abortion 
when she wants to keep the pregnancy.  Not only do these actions drastically increase risk for 
unintended pregnancy,7,11 but as condom nonuse is a strong component of RC, women’s risk of 
STI infection may be increased as well. The American College of Obstetricians and 
Gynecologists (ACOG) currently recommends regularly screening all reproductive-aged women 
for RC and offering specific harm-reduction strategies, such as hidden contraceptive options.19 
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Recent research has confirmed the occurrence of RC and its association with IPV. 
Among female clients of family planning clinics (ages 16-29 years in both studies), 25% had 
ever experienced reproductive coercion7 and 5% had experienced it in the past 3 months.11 
Prevalence estimates differed by IPV status, with 35% of IPV victims reporting lifetime RC 
compared to 15% in non-IPV victims.7 Similarly, 32% of women ages 18-44 years who had ever 
experienced RC also reported IPV within that relationship.20 IPV documented in medical record 
data is associated with more frequent contraception method changing among family planning 
clinic users.21 This indicates that there is significant overlap among the types of violence males 
perpetrate on their female partners, resulting in the potential for serious poor sexual and 
reproductive health outcomes. 
At this time, it is unclear how extensively ACOG’s recommendation to universally screen 
adolescent and adult women for IPV and RC has been implemented in daily clinical practice. 
Despite a longstanding recommendation to screen for domestic violence22,23 and its acceptability 
by female patients,24-26 reports indicate that screening and documenting are not implemented 
well in clinical settings.27 Similar limitations would be expected with RC as a sensitive topic but 
has not been examined to date. 
Patterns of contraceptive use by women who are experiencing male partner control over 
their reproductive and sexual decision making are not well elucidated in the current literature.  
Why some women are able to cope with RC by surreptitiously using female-controlled 
contraception or ending relationships while other women experience unintended pregnancies and 
other negative outcomes remains an important question. Additionally, identifying factors that are 
associated with better or worse outcomes for women experiencing IPV and RC is needed to 
guide interventions that may reduce the risk for poor health outcomes in the context of IPV/RC.  
9 
2.2. MALE PARTNER INFLUENCES ON FEMALE REPRODUCTIVE AND 
SEXUAL HEALTH 
2.2.1. Reproductive and sexual health outcomes 
Reproductive and sexual health outcomes have received special attention in the IPV literature, as 
pregnancy is a time when women may be particularly vulnerable to increasing abuse with poor 
outcomes for women and infants. Estimates of IPV during pregnancy in adult women range from 
4% to 15%,28,29 with rates as high as 29% in pregnant teenagers.30 Almost half of women who 
experience IPV during pregnancy report that the frequency of violence increased during the 
perinatal time period.29 
Evidence indicates that experiencing IPV before or during pregnancy is associated with 
poor perinatal and post-partum outcomes; these associations persist after controlling for other 
risk factors, such as delayed prenatal care and alcohol/tobacco use during pregnancy. Silverman 
and colleagues (2006) found that, compared to new mothers with no past-year physical IPV, new 
mothers who had experienced IPV both before and during pregnancy or during pregnancy only 
were less likely to receive early (first trimester) prenatal care and were more likely to smoke 
during the third trimester.28 Controlling for these risk factors, women who were abused during 
pregnancy only or both prior to pregnancy and during were still more likely to have preterm 
labor, vaginal bleeding, kidney infection/UTI, ER visit or hospitalization prior to delivery, and 
low birth weight babies, compared to women who did not experience physical IPV.28  Specific to 
adolescents, previous abuse was associated with previous miscarriages and infant birth weight 
among 18-19 year olds.31 Subsequent work has generally supported these associations.32 
Past experiences of IPV can result in poor pregnancy-related outcomes even in the 
absence of prenatal IPV. In the study by Silverman, women with a lifetime history of physical 
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IPV (excluding the prenatal period) were significantly more likely to have a history of pregnancy 
loss.33 Women who experienced IPV in the year prior to pregnancy but not during pregnancy had 
increased risks of preterm labor, diabetes, kidney infection/UTI, premature rupture of 
membranes, preterm delivery, low birth weight, and infant needing ICU care at birth compared 
to never-abused women after adjusting for relevant confounders such as race, smoking, and 
age.28 These women were also less likely to receive early (first trimester) prenatal care and more 
likely to smoke and use alcohol during the third trimester. These risk behaviors were controlled 
for in the final models that assessed reproductive health outcomes of physical IPV prior to 
pregnancy to tease apart the effects of IPV and associated risk behaviors during pregnancy, 
indicating that IPV independently contributes to these poor reproductive health effects.28 Overall, 
the reproductive health effects of IPV are long-lasting and not just the result of physical harm 
during pregnancy. 
Among the myriad reproductive and sexual health consequences of IPV/RC, the focus of 
this project is unintended pregnancies and sexually transmitted infections (STIs). 
Unintended pregnancies. Unintended pregnancies are common in the United States, 
accounting for 37% of all births in 2006-2010.34 Younger women bear the greatest burden of 
unintended births, with 77% of births to 15-19 year olds and 50% of births to 20-24 year olds.34 
Considering all pregnancies regardless of outcome (i.e., live birth or not), the proportion of 
unintended pregnancy reaches 51%.35 Disparities exist by race/ethnicity, income level, and 
education, such that unintended pregnancies are more common among racial and ethnic 
minorities and those with low income and educational attainment.36  
IPV is strongly associated with unintended pregnancies.37,38 Among live births, a 
significantly higher proportion of women who experienced physical abuse during pregnancy 
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reported that their pregnancies were unintended, including pregnancies being unwanted (9.9%) 
or earlier than desired (6.9%), compared to intended pregnancies (3.1%).39 There is also 
evidence that IPV is linked to unintended pregnancies specifically among adolescent women. 
Adolescent pregnancies are largely unintended,34 and ever experiencing dating violence is 
associated with higher odds of pregnancy during this developmental period.6,12,40 
 The past few years have shown an increased interest in the overlap between IPV, RC, and 
unintended pregnancy, with evidence indicating significant associations (see Table 1 for key 
studies).7,11 Odds of reporting a past unintended pregnancy were significantly higher when 
reporting RC, IPV, or both.7,11 Women with a history of IPV report greater difficulty from 
partners in obtaining and using contraception41; not surprisingly, each additional pregnancy these 
women experience is associated with higher odds of having experienced IPV.41 Examining the 
associations between contraceptive use factors and IPV illustrate the pathways by which negative 
male partner influence can lead to unintended pregnancies, including partners making it difficult 
for the woman to use birth control or wanting to get them pregnant. This work begins to establish 
temporality, heretofore only suggested in qualitative interviews, between partners’ control over 
reproductive and contraceptive behaviors and contraceptive nonuse.
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Table 1. Key studies on intimate partner violence, reproductive coercion, and unintended pregnancy 
Author 
(Year) 
Population and 
sample size 
Measures Results Comments 
Miller 
(2010)7 
Female family 
planning clinic 
patients 16-29 
years, based 
survey as part of 
a pilot IPV/RC 
intervention 
(n=1278) 
Reproductive coercion 
‘Has someone you were dating or going out with ever… 
1) told you not to use any birth control (like the pill, shot, 
ring, etc.)?; 2) said he would leave you if you didn’t get 
pregnant?; 3) told you he would have a baby with someone 
else if you didn’t get pregnant?; 4) hurt you physically 
because you did not agree to get pregnant?; and 5) tried to 
force or pressure you to become pregnant?  
6) taken off the condom while you were having sex so that 
you would get pregnant?; 7) put holes in the condom so 
you would get pregnant?; 8) broken a condom on purpose 
while you were having sex so you would get pregnant?; 9) 
taken your birth control (like pills) away from you or kept 
you from going to the clinic to get birth control so that you 
would get pregnant?; 10) made you have sex without a 
condom so you would get pregnant? “Have you ever 
hidden birth control from a sexual partner because you 
were afraid he’d get upset with you for using it?” 
Lifetime physical/sexual IPV 
‘Has someone you were dating or going out with ever… 
1) hit, pushed, slapped, choked or otherwise physically 
hurt [you], 2) insisted (without using force or threats) on 
having sex (vaginal, oral, or anal sex) with you when you 
didn’t want to? 3) used threats to make you have sex 
(vaginal, oral, or anal sex) with them?, and 4) used force 
(hitting, holding down, using a weapon) to make you have 
sex (vaginal, oral, or anal sex) with them?’ 
Sexual health behaviors/outcomes 
Unintended pregnancy (‘How many times have you been 
pregnant when you didn’t want to be?’) 
• 53% lifetime IPV 
• 19% pregnancy coercion 
• 15% birth control sabotage 
• 41% history of unintended pregnancy 
Models predicting UIP by RC and IPV 
AOR(95% CI) 
Reproductive coercion (RC) 
• RC only: 1.01 (0.62-1.63) 
IPV only: 1.11 (0.84-1.46) 
• Both: 1.99 (1.11-3.58) 
Pregnancy coercion (PC) 
• PC only: 1.05 (0.60-0.88) 
• IPV only: 1.14 (0.88-1.83) 
• Both: 2.22 (1.14-4.32) 
Birth control sabotage (BCS) 
• BCS only: 1.11 (0.56-2.19)  
• IPV only: 1.26 (0.97-1.62) 
• Both: 1.60 (0.73-3.48) 
Stratified by violence 
• RC, PC, and BCS unassociated with UIP 
among those not having experienced IPV 
• RC, PC, and BCS all significantly 
associated with UIP among those who 
experienced IPV 
• High risk population 
• Doesn’t assess 
emotional/psychological 
abuse 
• Temporality: cross-
sectional data only on 
lifetime experiences 
• Models adjusted for age, 
clinic site, 
race/ethnicity, and 
nativity 
Miller 
(2014)11 
Female family 
planning clinic 
patients 16-29 
years, based 
survey as part of 
Recent reproductive coercion 
10 items measuring reproductive coercion in the past 3 
months; see Appendix 
Lifetime physical/sexual IPV 
Three items measuring lifetime physical and sexual IPV; 
• 46% history of IPV 
• 5% RC 
• 12% past-year UIP 
Associations with UIP 
AOR (95% CI) 
• Temporality: lifetime 
assessment of IPV, past-
year UIP, recent RC (is 
recent RC a proxy for 
RC experiences at time 
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an IPV/RC 
intervention 
(n=3539) 
see Appendix 
Past-year unintended pregnancy 
Seven items from the NSFG, modeled as a summary score; 
see Appendix 
• Yes IPV / yes RC: 2.00 (1.15-3.48) 
• Yes IPV / no RC: 1.80 (1.42-2.26) 
• No IPV / yes RC: 1.79 (1.06-2.03) 
of conception?) 
• High-risk population 
• Doesn’t assess 
emotional abuse 
Gee 
(2009)41 
Female patients at 
Planned 
Parenthood in 
Philadelphia, ≥18 
years (n=1354) 
Lifetime physical/sexual IPV 
“Has an intimate partner ever… 1) threatened physical 
violence, 2) attempted physical violence, 3) committed 
physical violence, 4) had unwanted sex by a current or 
former partner, 5) past-year injuries to physical violence or 
unwanted sex  
Sexual health behaviors 
condom and other contraceptive use 
factors/barriers  associated with contraceptive non-use 
• 21% reported IPV 
• IPV not associated with using a condom 
(49% vs 46%, p=0.35) or type of 
contraceptive used recently (p=0.33) 
Associations with IPV 
AOR (95%CI) 
• Not using birth control because ‘partner 
didn’t feel like using it or wanted you to get 
pregnant’: 2.34 (1.41-3.89) 
• Agreeing that ‘my partner makes it difficult 
to use birth control’: 12.78 (1.68-4.63) 
• Agreeing that ‘skipped using birth control 
because can’t afford it’: 2.02 (1.68-4.63) 
• Going without birth control in the past 4 
months: 1.16(0.81-1.66) 
• Temporality: lifetime 
assessment of IPV, but 
contraceptive use 
unclear on timing (some 
past 4 months, some 
‘recently,’ etc.) 
• High-risk population 
• Doesn’t assess 
emotional abuse 
IPV, intimate partner violence; RC, reproductive coercion; UIP, unintended pregnancy; PC; pregnancy coercion; BCS, birth control 
sabotage; AOR, adjusted odds ratio
Table 1 Continued 
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IPV has been associated with unintended pregnancies across populations, suggesting that 
women victimized in their relationships have less power to decide upon and use effective 
contraception.42,43 The majority of work at this time is cross-sectional, thus studies are needed to 
establish temporal trends. As not all women in abusive relationships have unintended 
pregnancies, protective factors should be identified for future preventive efforts. 
Sexually Transmitted Infections (STIs). STIs are a major public health concern, as one in 
four adolescent girls is infected44 and adolescents and young adults between the ages of 15 and 
24 represent half of new STI cases.45 In addition to the short-term consequences of untreated 
STIs, including symptoms and increased susceptibility to HIV infection, STIs increase 
reproductive health morbidity. Chlamydia and gonorrhea are associated with pelvic 
inflammatory disease (PID).46 PID, in turn, is associated with poor reproductive health outcomes, 
including infertility, chronic pelvic pain, recurrent PID, and ectopic pregnancy.46  
Much of the evidence to date supports a positive association between IPV and risk of 
STIs; key and recent studies are presented in Table 2. Lifetime exposure to physical/sexual or 
physical only IPV has been associated in females with a history of STIs,47-49 being afraid to 
notify a partner of an STI,50 being less likely to seek STI treatment or testing,50 having faster 
time-to-STI incidence,51 and testing positive for a current STI48; lifetime, but not current, 
physical/sexual IPV was associated with testing positive for an STI in one study.49 Experiencing 
sexual IPV only has been associated with decreased odds of testing positive for an STI at a single 
time point, likely due to increased prior care-seeking for testing (and therefore treatment)48; this 
is supported by a higher proportion of these women self-reporting an STI diagnosis in the past 
year.48 This differential risk by type of IPV, specifically presence or absence of sexual IPV, is 
also supported by a study that found that lifetime and current physical/verbal IPV was not 
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associated with a self-reported history of STI,52 suggesting that when measures of IPV do not 
include sexual abuse occurring in such relationships, the STI risk may be underestimated.  
Studies of male perpetrators of IPV support an association between IPV and STIs. 
Among 14-20 year old heterosexually active male clients of adolescent health clinics, 
perpetrating teen dating violence was associated with a self-reported history of STI compared to 
never-perpetrators.53 
Many studies to date rely on either self-report or one-time specimen testing for current 
infections, possibly leading to biases by exposure, especially for those who are asymptomatic 
and may not have sought an STI test (self-report) and miss infections that had been previously 
diagnosed and treated or cleared on their own (specimen testing). As women who experience 
IPV exhibit greater healthcare seeking54,55 and are over-represented in family planning and STI 
clinics,8,10,47,56 STI tests at one point in time could result in bias. Findings would underestimate 
risk if more frequent STI testing and treatment decreased prevalence among women exposed to 
IPV compared to those who did not experience IPV (e.g., incidence may be higher, but shorter 
duration could decrease prevalence). Studies are needed that substantiate self-report with 
longitudinal medical record data and explore possible biases. 
STIs represent a common and serious outcome of IPV, but current research is limited by 
methodological inconsistencies across studies. The mechanisms by which women may be 
exposed, such as being afraid to request condom use or being pressured not to use condoms as a 
sign of “loyalty” or “love,” are also not well understood. Addressing the role of partner influence 
on STI acquisition is needed to identify potential mechanisms and intervention strategies to 
reduce the risk for STI acquisition and reinfection. 
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Table 2. Key and recent studies on the association between intimate partner violence and sexually transmitted infections in adolescent 
and young adult women 
Author 
(Year) 
Population and 
sample size 
Measures Results Comments 
Decker 
(2005)47 
Sexually active 
females in the 
Massachusetts 
Youth Risk 
Behavior Survey, 
grades 9th-12th, 
years 1999 and 
2001 (n=1641) 
Lifetime physical/sexual IPV  
“Have you ever been hurt physically or sexually by a date 
or someone you were going out with? This would include 
being hurt by being shoved, slapped, hit, or forced into 
any sexual activity.” (no, physical only, sexual only, 
both) 
Sexual risk behaviors/outcomes 
Ever HIV/STI tested, ever diagnosed with STI/HIV 
• 31.5% any physical or sexual IPV 
• 32.9% ever testing for STIs/HJIV 
• 4.7% STI diagnosis 
Odds of testing for STIs only 
• Sexual only: 1.38 (0.58-3.29) 
• Physical only: 1.63 (1.02-2.62) 
• Both: 2.41 (1.38-4.22) 
HIV testing only 
• Sexual only: 1.17 (0.31-4.38) 
• Physical only: 1.14 (0.44-2.91) 
• Both: 1.28 (0.43-3.76) 
Both STIs/HIV 
• Sexual only: 1.93 (1.02-3.63) 
• Physical only: 1.11 (0.73-1.68) 
• Both: 3.00 (1.93-4.66) 
STI/HIV diagnosis 
• Sexual only: 1.96 (0.77-4.97) 
• Physical only: 2.18 (1.13-4.21) 
• Both: 2.59 (1.05-6.35) 
• Adjusted for age, race, 
condom use at last 
intercourse, 2+ partners in 
last 3months 
• Sexual violence only is not 
associated with HIV/STI 
testing or diagnosis 
• Physical only or 
physical/sexual IPV 
associated with testing and 
diagnosis (stronger 
associated for 
physical/sexual) 
Decker 
(2011)50 
Sexually active 
female family 
planning clinic 
patients in 
California , ages 
16-29 (n=1282) 
Lifetime physical/sexual IPV (see Miller et al. 2010 in 
Table 1) 
Sexual health behaviors and outcomes: partner STI 
notification 
Fear of partner notification, history of partner 
notification, partner response to partner notification 
(‘when you told a sexual partner you got an STD from 
them, did they . . . seek treatment or testing?’, ‘tell you it 
wasn’t from them or accuse you of cheating?’, ‘threaten 
to hurt you physically or actually hurt you physically?’ 
• 53.3% reported physical/sexual IPV 
IPV associated with (ARR (95% CI)) 
• Fear of partner notification: 1.46 (1.20-
1.77) 
• Notified partner: 0.99 (0.93-1.05) 
Partner response to notification 
• Partner sought treatment: 0.93 (0.86-
0.99) 
• Said not from them or accused of 
cheating: 1.56 (1.24-1.98) 
• Threatened to harm or did harm: 1.17 (0.51-
2.67) 
• Cross-sectional 
• Adjusted for age, 
race/ethnicity, and 
recruitment site 
• Higher risk population 
Hess Female Past-year physical and sexual IPV • 7.1% prevalent STI • Original Wave I data were 
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(2012)48 participants in the 
Add Health 
Study, Wave III, 
who were 
sexually active in 
heterosexual 
relationships in 
past three months 
and consented to 
STI testing, 18-28 
years old 
(n=3,548) 
Physical IPV: perpetrator-only, victim-only, reciprocal, 
nonabusive 
Sexual IPV: victim-only Sexual health behaviors and 
outcomes 
Positive STI result (C. trachomatis, N. gonorrhoeae, and 
T. vaginalis); condom use at last intercourse 
 
• 31.8% used condom at last intercourse 
IPV status 
• 17% reciprocal abuse 
• 3% victim-only 
• 12% perpetrator-only 
• 8% sexual victimization 
Prevalent STI 
• Reciprocal: 0.5 (0.63-1.43) 
• Victim-only: 2.06 (1.01-4.21) 
• Perp-only: 1.26 (0.84-1.88) 
• Sexual victim: 0.48 (0.26-0.87) 
• Condom use last intercourse: 1.00 (0.73-
1.36) 
• # past-year sex partners: 1.06 (0.99-1.13) 
Condom used last intercourse 
• Reciprocal: 0.79 (0.62-0.99) 
• Victim-only: 0.58 (0.34-0.97) 
• Perp-only: 0.90 (0.71-1.15) 
• Sexual victim: 0.91 (0.68-1.23) 
• # PY sex partners: 0.94 (0.88-1.00) 
representative of 7th-12th 
grade students 
• Restricted subsample more  
• Only looks at most recent 
“important” relationship 
• IPV estimates low given the 
literature 
• Adjusted for physical IPV, 
sexual IPV, race/ethnicity, 
age, education, level of 
commitment, age 
discordance, partner has 
concurrent partners, condom 
use at last vaginal 
intercourse, and past-year 
drug use, heavy drinking, sex 
trade for money, # of sex 
partners 
• temporality 
Reed 
(2014)53 
Cross-sectional 
survey of males 
at adolescent 
health clinics in 
Boston who ever 
reported 
heterosexual sex, 
14-20 years old 
(n=134) 
IPV perpetration 
Physical, sexual, and psychological violence 
Sexual health behaviors and outcomes 
Ever diagnosed with an STI, consistent condom use in 
past three months (‘always’ = consistent) 
• 14.9% history of STI 
• 35.8% consistent condom use past 3 months 
IPV perpetration AOR (95% CI) 
• History of STI: 3.3 (1.2-9.2) 
• Consistent condom use: 0.8 (0.4-1.6) 
• IPV perpetration associated 
with STIs but not consistent 
condom use 
• Models adjusted for living 
situation (no other significant 
demographics) 
Roberts, 
Auinger, 
 & Klein 
(2005)52 
Sexually active, 
dating females in 
the Add Health 
study, ages 13-22 
years (n=973) 
Verbal/physical IPV  
Past verbal abuse, physical abuse, current verbal abuse, 
current physical abuse 
Reproductive health outcomes 
No condom or contraception use at most recent 
intercourse, history of STI or pregnancy 
• 13% current verbal abuse 
• 6% current physical abuse 
• 23% past 18 month verbal abuse 
• 15% past physical abuse 
• 48% condom nonuse at last intercourse 
Logistic regression model results AOR(95% 
CI) 
Any history of STIs 
• Past verbal: 1.47 (0.81-2.70) 
• Sexual IPV not captured 
• Contraception measure 
included condoms as well (as 
opposed to female-controlled 
methods only) 
• Adjusted for history of 
sexual coercion 
• Specific to adolescents 
• Nationally representative of 
Table 2 Continued 
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• Past physical: 1.61 (0.86-3.03) 
• Current verbal: 0.90 (0.39-2.04) 
• Current physical: 1.37 (0.58-3.23) 
Any history of pregnancy 
• Past verbal: 1.43 (0.86-2.33) 
• Past physical: 2.27 (1.35-3.85) 
• Current verbal: 1.37 (0.77-2.44) 
• Current physical: 3.33 (1.72-6.25) 
those in school at Wave I 
• Cross-sectional 
Table 2 Continued 
19 
2.2.2. Mechanism of interest: contraceptive use and nonuse 
A major contributing factor to unintended pregnancies and STIs is condom and contraceptive 
nonuse.  When possible, condom nonuse is considered separately from other contraceptive use, 
as condom use specifically refers to a male partner using a condom (not the use of female 
condoms).  In examining male partner influences on reproductive and sexual health outcomes, it 
is critical to distinguish between contraception that involves male behavior (condom was or was 
not used) and female behaviors (access to and use of hormonal contraceptive methods) as the 
pathways for male partner influence are likely to be different.  
At a national level, contraceptive nonuse is common; 18.7% of 15-19 year olds and 
14.3% of 20-24 year olds considered ‘at risk for pregnancy’ report not currently using any 
contraceptive method .57,58 These proportions are higher than in any other age groups.  Roughly 
half of adolescent and young adult women identified as ‘at risk for pregnancy’ use oral 
contraceptives (‘the pill’) as their most effective method of contraception (54% and 48% among 
15-19 and 20-24 year olds).57,58 Almost one in four sexually active 15-19 and 20-24 year olds 
report using condoms as the primary pregnancy prevention method (22.8% and 24.5%, 
respectively).57,58  Intrauterine devices (IUDs), which are a highly effective, long-acting 
reversible contraceptive option, are not well utilized in these populations (3.6% and 5.9%, 
respectively).57,58 Among high school students, there was an overall increase in condom and 
other contraceptive usage between 1991 and 2007, but the greatest increase occurs between 1991 
and 2003 before plateauing from 2004 to 2007.59  
A compounding problem with contraceptive nonuse is that once a female tries a given 
method, chances of discontinuation are high. Of the women who tried any contraceptive method, 
30% stopped using oral contraceptives, 11% stopped using condoms, 43% stopped using a 
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hormonal contraceptive injection, and 50% stopped using a hormonal contraceptive dermal 
patch.58 
Past discontinuation or nonuse of contraception is a strong predictor of future nonuse. 
Condom use during adolescence is associated with condom use six months60 and five years 
later.61 Greater partner sexual communication was associated with decreased odds of inconsistent 
contraceptive use,60 suggesting that more positive relationships around sex are protective against 
risky behaviors. Also of note, a positive STI history was not associated with inconsistent 
contraceptive use.60 While a decreased odds of inconsistent use following an STI would suggest 
that adolescents change behaviors following adverse outcomes (e.g., infection), this null finding 
indicates that condom use behavior is hard to change, even when given motivating factors such 
as past STIs. 
Condoms serve a dual purpose, protecting against both pregnancies and STIs. Unlike 
other forms of contraception, condom usage requires knowledge and cooperation from male 
partners. Women who experience IPV, RC, or other forms of abuse within dating relationships 
may be at a greater disadvantage to negotiate condom use, risking both perceived and actual 
consequences to requests. 
Adult women who report IPV are more likely to also report less frequent condom use43,62 
and to request condom use less frequently62 compared to non-abused women. Results among 
adolescents and young adult women are less conclusive; key studies are presented in Table 3. 
Current verbal abuse52 is associated with condom nonuse while past52 or lifetime61 verbal is not. 
Past or lifetime physical IPV is associated with condom use in some6 but not all52,61 studies; 
similarly, current physical IPV is a significant predictor in some samples61 but not all.52 Lifetime 
sexual IPV or forced sex is not associated with condom nonuse6,61 but combined physical IPV 
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and sexual IPV/forced sex are associated in the same studies.6,61 Inconsistencies across studies 
examining IPV and condom use may be the result of study design differences and differences in 
abuse measures. 
Research with men supports an association between IPV and contraceptive nonuse. One 
study asked heterosexual men to report past-year physical violence and past-month condom 
usage. After controlling for possible confounders (condom use self-efficacy and outcome 
expectancies, participant age, partner pregnancy desire, and HIV status), men who perpetrated 
moderate to severe violence against their female partners were half as likely to report using 
condoms consistently compared to those who did not perpetrate moderate or severe IPV 
(OR=0.49, 95% CI 0.27-0.86).63 
Women experiencing IPV have an impaired ability to negotiate condom use. Young 
women who experience IPV report greater fear of requesting condom use,14,40,43 experiencing 
violence,  threats of violence, and other negative consequences from requesting condom use,14,64 
and being coerced into not using a condom during sex.14 Not surprisingly, these women are also 
less likely to use condoms consistently.40,65  
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Table 3. Key studies on the association between intimate partner violence and condom nonuse in adolescent and young adult women 
Author 
(Year) 
Population and 
sample size 
Measures Results Comments 
Roberts, 
Auinger, 
 & Klein 
(2005)52 
Sexually active, 
dating females 
in the Add 
Health study, 
ages 13-22 years 
(n=973) 
Verbal/physical IPV  
Past verbal abuse, physical abuse, current verbal abuse, 
current physical abuse 
Reproductive health outcomes 
No condom or contraception use at most recent 
intercourse, history of STI or pregnancy 
• 13% current verbal abuse 
• 6% current physical abuse 
• 23% past 18 month verbal abuse 
• 15% past physical abuse 
• 48% condom nonuse at last intercourse 
Logistic regression model results AOR(95% 
CI) 
Condom nonuse 
• Past verbal: 1.24 (0.86-1.77) 
• Past physical: 0.87 (0.57-1.33) 
• Current verbal: 1.56 (1.02-2.40) 
• Current physical: 1.42 (0.79-2.55) 
• Sexual IPV not captured 
• Contraception measure 
included condoms as well 
(as opposed to female-
controlled methods only) 
• Adjusted for history of 
sexual coercion 
• Specific to adolescents 
• Nationally representative 
of those in school 
• Cross-sectional 
Silverman 
et al. 
(2001)6 
Female 9th-12th 
grade students 
who participated 
in the 
Massachusetts 
Youth Risk 
Behavior Survey 
in 1997 and 
1999 (n=1977 
and n=2186, 
respectively) 
Lifetime physical/sexual IPV 
Report whether they had “ever been hurt physically or 
sexually by a date or someone they were going out with. 
This would include being shoved, slapped, hit, or forced 
into any sexual activity.” (none, physical only, sexual 
only, both physical and sexual) 
Sexual risk behaviors and outcomes 
Condom nonuse at last intercourse, , ever been pregnant 
Prevalence 
• 20.2% and 8% physical or sexual IPV 
1997 AORs (95% CI) 
Condom nonuse last intercourse 
• Phys only: 2.0 (1.3-3.0) 
• Sexual only: 1.3 (0.7-2.3) 
• Both: 0.9 (0.5-1.5) 
Pregnancy history 
• Phys only: 2.5 (1.4-4.5) 
• Sexual only: 1.8 (0.7-4.9) 
• Both: 6.3 (3.4-11.7) 
 
1999 AORs (95% CI) 
Condom nonuse last intercourse 
• Phys only: 1.3 (0.9-2.0) 
• Sexual only: 1.4 (0.8-2.5) 
• Both: 1.0 (0.6-1.7) 
Pregnancy history 
• Phys only: 2.2 (1.2-4.0) 
• Sexual only:  3.2 (1.5-6.8) 
• Both: 3.9 (1.9-7.8) 
• Cross-sectional 
• Condom nonuse generally 
unassociated with any IPV 
(exception physical IPV 
only in 1997) 
•  Representative sample of 
high school girls in 
Massachusetts (excludes 
those not in public 
schools) 
• Does not include 
information on non-
condom contraception 
• Does not include 
emotional abuse 
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Teitelman 
et al. 
(2008)61 
Females 
enrolled during 
grades 7th-12th 
into the Add 
Health Study 
who completed 
Waves II (11-21 
years old) and II 
(18-26 years 
old)  and were 
sexually active 
at Wave III 
(n=2,058) 
Recent IPV (verbal/physical/sexual) (since Wave II) 
Sexual risk behaviors and outcomes 
frequency of condom use, condom use during last 
intercourse, STI diagnosis 
Past emotional or physical abuse (between Waves I and 
II or last 18 months) 
 
• 18% used condoms all the time in the past 
12 months at Wave II 
Odds of using condoms all the time at Wave 
III (OR (p-value)) 
Prior abuse at Wave II 
• Never physical: 1.53 (0.096) 
• Never verbal: 1.42 (0.093) 
• No to both: 1.68 (0.112) 
Recent abuse at Wave III 
• No physical/verbal: 1.66 (<.001) 
• Never forced sex: 1.52 (0.054) 
• No phys/verbal or forced sex: 1.82 (0.042) 
Combined effects of abuse 
• Wave II only: 0.77 (0.262) 
• Wave III only: 0.61 (0.001) 
• Both: 0.48 (0.014) 
• Initial enrollment was 
nationally representative 
of 7th-12th graders in the 
United States  
• Models not adjusted 
• Past physical abuse not 
associated with future 
condom nonuse 
• Recently non-abused more 
likely to use condoms all 
the time 
• Indications of a 
cumulative effect 
• No information on non-
condom contraception 
Table 3 Continued 
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Unlike condoms, other contraceptive methods largely can be hidden from male partners’ 
knowledge. These methods include oral contraceptives, dermal patches, vaginal rings, and long 
acting reversible contraceptives such as IUDs, implants, and injections. Despite the apparent 
appeal of these methods for those in risky relationships, they are underutilized options for young 
women.57,58 
Among 16-24 year old women who initiated oral contraceptive use at baseline, only 19% 
were continuing to use oral contraceptives one year later; perceived susceptibility to pregnancy 
was unassociated with contraceptive and condom use one year later.66  This supports earlier work 
that indicates high rates of contraceptive discontinuation and aversion in this age group.67-69 
However, IPV and other relationship characteristics were not assessed in this study, preventing 
examination of partner influence on contraceptive choices. In studies that assess the impact of 
IPV on contraceptive use (Table 4), there is evidence that IPV is associated with more 
contraceptive method changes21 and contraceptive nonuse 21,70 in some studies but was not 
associated with contraceptive nonuse in others.52,71  
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Table 4. Key studies on the association between intimate partner violence and non-condom contraceptive use 
Author 
(Year) 
Population and 
sample size 
Measures Results Comments 
Williams 
et al. 
(2008)71 
Female patients 
in health care 
settings (EDs, 
obgyn, peds, 
primary care, 
addiction 
recovery), ≥ years 
who agreed to 
follow-up and 
had past-year 
male partner 
(n=225, 115 
abused 110 
controls) 
Contraceptive use 
Past 12 months, if use >1, use most effective method 
chosen 
Discrepancy between actual and preferred method: select 
which method most prefer to use; if not using, coded as 
discrepant 
Past-year IPV 
CTS2 scale; no abuse, physical only, physical and/or 
emotional 
Sexual abuse separate 
• 14.2% used no contraception 
• 7.6% preferred no contraception 
• Abused less likely to use pills (27.8% vs 
46.4%, p<.01) and more likely to use 
condoms (33.0% vs 20.9%, p=0.04) 
Contraceptive nonuse 
AOR (95% CI) 
• Any abuse: OR=1.7 (0.8-3.7) 
• Physical only: 2.7 (0.8-9.5) 
• Phys ± emotional: 1.8 (0.7-4.8) 
• Sexual violence: OR=1.3 (0.6-2.9) 
Contraceptive discrepancy 
AOR (95% CI) 
• Any abuse: OR=1.5 (0.8-2.9) 
• Physical only: 0.8 (0.3-2.2) 
• Phys ± emotional: 1.5 (0.7-3.1) 
• Sexual violence: OR=0.9 (0.4-1.7) 
• Potential participants 
approached even if with 
partner 
• Low participation rate (not 
interested, language barrier, 
not feeling well), not 
approached because ill, 
distressed, or acute injuries, 
• 50% follow-up 
• Adjusted for type of abuse, 
age, relationship status, sex 
in past 30 days 
• Does not capture patterns of 
use over time (“used at least 
once in past 12 months” 
versus “did not use at all in 
past 12 months”) 
• Abuse unassociated with 
past-year contraceptive 
nonuse or contraceptive 
discrepancy 
Roberts, 
Auinger, 
 & Klein 
(2005)52 
Sexually active, 
dating females in 
the Add Health 
study, ages 13-22 
years (n=973) 
Verbal/physical IPV  
Past verbal abuse, physical abuse, current verbal abuse, 
current physical abuse 
Reproductive health outcomes 
No condom or contraception use at most recent 
intercourse, history of STI or pregnancy 
• 13% current verbal abuse 
• 6% current physical abuse 
• 23% past 18 month verbal abuse 
• 15% past physical abuse 
• 48% condom nonuse at last intercourse 
Logistic regression model results AOR(95% 
CI) 
Contraception nonuse 
• Past verbal: 1.29 (0.87-1.91) 
• Past physical: 1.08 (0.68-1.71) 
• Current verbal: 1.33 (0.84-2.11) 
• Current physical: 1.57 (0.88-2.81) 
 
• Sexual IPV not captured 
• Contraception measure 
included condoms as well (as 
opposed to female-controlled 
methods only) 
• Adjusted for history of 
sexual coercion 
• Specific to adolescents 
• Nationally representative of 
those in school at Wave I 
• Cross-sectional 
 
 
26 
 
Fantasia 
et al. 
(2012)21 
Reproductive-
aged female 
clients of four 
reproductive 
health clinics 
with at least 1 
annual 
gynecological 
exam 2006-2011 
(n=2000) 
Lifetime physical and sexual IPV 
“have you ever been abused/felt unsafe in a relationship: 
(physical/emotional/sexual) threats or violence,” “have you 
ever been forced to have sex when you didn't want to?” 
Timing: 1) IPV in the past year only, 2) past year IPV and 
during the past 5 years, 3) P-Y IPV plus violence 
extending for greater than 5 years and 4) no P-Y 
experiences but a previous history of IPV 
Reproductive health outcomes 
current contraceptive method, use of a “hidden” method 
(injectable and implantable progestins, IUD, sterilization), 
number of  PY method changes, contraceptive method 
nonuse, 
• 29% lifetime IPV 
• 6% past-year IPV only 
• 3% P-Y IPV & past 5 years 
• 2% P-Y IPV & >5 years 
• 18% no P-Y IPV & history of IPV 
• 13% hidden contraceptive method 
• Women in all violence categories had more 
frequent method changes in past year 
IPV and using hidden contraceptive 
method  
AOR (95% CI) 
• P-Y IPV only: 2.5 (1.4-4.4) 
• P-Y IPV & past 5 years: 5.4 (2.8-10.5) 
• P-Y & > 5 years: 2.7 (1.2-6.4) 
• No P-Y IPV & history of IPV: 2.5 (1.8-3.6) 
IPV and not using birth control  
AOR (95% CI) 
• P-Y IPV only: 9.7 (6.2-10.5) 
• P-Y IPV & past 5 years: 9.8 (5.8-18.3)  
• P-Y & > 5 years:  7.7 (3.3-17.6) 
• No P-Y IPV & history of IPV: 4.9 (3.5-7.0) 
• Excluded women who 
experienced violence during 
childhood but not currently 
experiencing IPV 
• Models adjusted for race, 
ethnicity, age, education, 
employment, STI history 
• Unclear how well IPV 
screening was implemented 
and recorded in the medical 
record data 
Table 4 Continued 
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Male partners who perpetrate physical, sexual, emotional, or reproductive violence 
against their adolescent and young adult female partners frequently refuse to use condoms and 
create an environment in which the young women perceive threats or consequences to requesting 
condom use. Similarly, IPV is indicated as a risk factor for other contraceptive method nonuse. 
The majority of research on adolescents and young adults is not able to identify temporal 
patterns due to reliance on cross-sectional surveys. Limited conclusions can be made about how 
negative partner influence may affect contraceptive use over time in this particularly vulnerable 
population. Studies are needed that identify factors contributing to contraceptive nonuse or use of 
less effective contraceptive methods, with close attention to the ways partners may influence 
these behaviors in the context of IPV.   
This project will address these current limitations in the literature. Aim 2 will assess 
partner influence on contraceptive use in a nationally representative cross-sectional sample of 
15-24 year old women. Patterns of condom use, contraceptive method initiation and 
discontinuation, and reasons for nonuse will be assessed via self-report over a twelve month 
period.  This will build on the current literature that indicates method nonuse and discontinuation 
with more detailed partner influence measures and identifying classes of women who are and are 
not exposed to partner influence. Aim 3 will address current methodological limitations.  
2.3. METHODOLOGICAL LIMITATIONS OF CURRENT RESEARCH 
The research to date on male partner influence on women’s sexual health is limited by a number 
of methodological concerns. Problems with accurate exposure and outcome ascertainment, 
temporality, and selection biases preclude conclusions on the pathways leading to poor sexual 
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health outcomes. This project focuses specifically on these measurement challenges when 
collecting data via self-report or medical record abstraction. While the concordance between 
self-report and medical record data is relatively unexplored in the IPV literature, one study of 
poor pregnancy outcomes found low agreement between these data sources.72  
Compared to other medical and public health concerns such as obesity, IPV is 
particularly difficult to study given high levels of shame, isolation, and stigma that limit case 
identification. The majority of studies on IPV/RC and sexual health outcomes rely solely on self-
report (e.g., Silverman et al. 2001,6 Miller et al. 20107), with few incorporating medical record 
data (e.g., Johnson & Hellerstedst 2002,49 Fantasia et al. 201221). Self-report requires women to 
1) be recruited into studies on violence, 2) recognize the behaviors listed on a survey as being
consonant with their own experiences, and 3) feel comfortable endorsing these behaviors on a 
survey or to an interviewer. Conversely, collecting data via medical record charts is limited by 1) 
women receiving health care services, 2) providers feeling comfortable discussing and asking 
women about IPV, RC, and other sensitive topics, 3) women disclosing their experiences, and 4) 
providers documenting these conversations. Studies that rely solely on self-report or on medical 
record review are likely to underestimate the prevalence of IPV in that clinic population. ACOG 
released its recommendation to universally screen reproductive-aged women for reproductive 
coercion in 2013,19 but it is likely that these recommendations are slow to be implemented in 
clinical practices. It is likely that even with these recommendations, data collected in medical 
records are either missing IPV/RC documentation or have been collected in a biased manner 
(e.g., at the clinician’s discretion). Thus, ascertaining exposure to IPV likely varies by data 
collection method, resulting in information bias. 
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A second source of bias, social desirability bias is also possible when ascertaining IPV as 
well as sexual and reproductive health behaviors and outcomes. Social desirability bias occurs in 
sexual health research when reporting undesirable or sensitive behaviors directly to an 
interviewer compared to computer-assisted, self-administered questionnaires.73,74 Thus, self-
report as well as medical record data in which patients may have to directly disclose to their 
providers are both likely to be limited by this social desirability bias. 
Temporality is another major gap in the IPV literature that often relies on cross-sectional 
data as noted above.  Medical record data are prospectively collected, allowing temporal 
associations to be explored. However, this often requires that individuals continue to see the 
same provider or group of providers to obtain a complete medical history, which may or may not 
be the case or may not be known to the investigators. Self-report data allow for repeated 
measures to begin to establish temporality as long as good strategies are in place for retaining 
patients in IPV studies.  It is likely that those women who are most impacted by IPV are less 
likely to have consistent medical care (i.e., medical record data will be incomplete) and to 
continue participation in a clinical research study.  Thus, while longitudinal data collection and 
medical record review offer the opportunity to explore temporal patterns, the extent to which 
women experiencing IPV are adequately represented in those data is not known. 
A final concern is the selection biases inherent in self-report and medical record data. 
When collecting medical record data from a particular healthcare institution, data from other 
institutions are likely missed. This has the potential to introduce considerable selection bias by 
the exposure of interest. For example, it is common in IPV/RC research to collect data from 
family planning clinics, where patients have higher rates of IPV and RC7,10,56; this excludes all 
chart data on healthcare seeking, testing, results, and procedures that occurred in general 
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practices, urgent care, emergency departments,  and private obstetrics/gynecology offices.  Care 
seeking behaviors, including the health care practices used, may vary based on particular health 
needs, such as using different organizations for STI testing and prenatal care. Further, women 
who intend pregnancy may be more likely to plan and then use private practices compared to 
clinics, creating possible biases. Institutions that offer a range of services (e.g., primary care, 
urgent care, emergency departments, and women’s health) are less suspect to biases from 
differential care seeking compared to facilities that offer only a select number of specific 
services.  
Conversely, women who expressly enroll in studies and are willing to answer sensitive 
questions via self-report on a computer survey may be quite different from the clinic population 
in general (for example, women represented in large secondary data-sets from a health care 
system) and the population at large. Given significant concerns about the safety of women 
participating in IPV studies, some protocols may specifically not approach women who present 
for care with a male partner7 while other studies approach women to tell them about a study 
regardless of partner presence.71 Those women who do participate likely differ in ways that are 
meaningful to the study (e.g., history of IPV, current acute trauma due to IPV).  
In addition to the limitations described above, the literature also shows that adolescents 
and young adults’ self-reports of STI and other sexual health behaviors and conditions have low 
concordance with medical record data75,76 or self-reports over time.77,78 However, it is unclear 
whether or how IPV and RC – especially given their associations with greater healthcare 
seeking54,55 -  may impact this variation across methods and populations and should be assessed.  
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As an example, consider research on partner violence and STI. Using self-report of IPV 
and biological specimens to test for current STI infections, investigators in one study found an 
association between physical and physical/sexual IPV and current STI infection, but those 
reporting sexual IPV only had a lower odds of having a current STI infection.48 If this had been 
the extent of the data collected, one could conclude that physical IPV may be riskier for poor 
sexual health outcomes than sexual IPV. However, the additional self-reported data on STI 
history indicated that those who experience sexual IPV are more likely to have received STI 
testing and have been diagnosed with an STI in the past year.48 Thus, the self-reported data 
provided a more complete picture of the association between IPV and sexual health outcomes, 
while the biological specimen testing confirmed successful treatment of past infections. 
For this study, the concordance of IPV/RC self-report and medical record documentation 
will be compared in this study to reproductive and sexual health outcomes, specifically 
documentation of pregnancies and STI.  Further, the impact that partner violence and pregnancy 
intention have on reporting concordance will be evaluated. This will allow researchers to make 
better informed decisions for future data collection in this vulnerable population. 
2.4. THEORETICAL FRAMEWORK: SOCIAL COGNITIVE THEORY 
Research to date points to the substantial influence partners may have on women’s reproductive 
health, contraceptive use, and decision-making. In an attempt to explain these phenomena, 
investigators have drawn heavily from Social Cognitive Theory (SCT), which is used widely in 
the health promotion literature. SCT was first proposed by Bandura as a social learning theory in 
1977.79 SCT states that human behavior is a result of personal, behavioral, and environmental 
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factors continuously interacting.79 It emphasizes both the social factors that influence an 
individual and the individual’s own capacity to exact changes on him- or herself and others, 
learn, and self-regulate.80
Perceived self-efficacy, defined by Bandura as “the conviction that one can successfully 
execute the behavior required to produce the outcomes,” (p. 193)79 is the cornerstone of SCT. 
Self-efficacy is both directly and indirectly related to multiple pathways leading to health 
behaviors.81 Briefly, self-efficacy impacts, among other things, how ambitious goals a person 
sets for him- or herself, outcome expectations, duration of effort, and perception of overcoming 
barriers.81 These pathways may help to clarify how partner influences may impact young 
women’s contraceptive behaviors and reproductive health. 
Given that self-efficacy is a person’s beliefs that he or she can accomplish certain tasks 
and goals, self-efficacy is best studied and understood in the context of specific domains81,82; as 
such, when examining sexual health and outcomes, self-efficacy specific to sexual activity needs 
to be considered.  However, it should first be noted that sexual self-efficacy is conceptualized 
differently across studies, despite calls to standardize.83 A review published in 2010 by Gloppen, 
David-Ferdon, and Bates highlights the heterogeneity across studies.84 For example, sexual self-
efficacy incorporates concepts such as “self-efficacy to refuse unwanted sex,” “self-efficacy to 
negotiate condom use,” and “self-efficacy to use condoms.” 
Evidence is relatively sparse on a possible relationship between IPV and sexual self-
efficacy, but findings to date indicate that recent experiences of IPV are associated with 
decreased sexual self-efficacy.85,86 However, these populations are restricted to older adult 
women. This possible relationship between IPV and sexual self-efficacy should be assessed in a 
more representative sample of adolescent and young adult women. 
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The relationship between self-efficacy and safer sex practices has been explored in the 
literature more thoroughly than the relationship with IPV, with findings indicating a positive 
association. Sexual self-efficacy has been associated with intended87 and actual condom use,87,88 
use of female-controlled contraceptive methods,88 not engaging in unprotected intercourse,88-90 
and refusing unwanted sex,91 in adolescent and young adult females. These findings indicate that 
the association between sexual self-efficacy and sexual health behaviors is well established in the 
literature. 
In contrast, few studies have assessed the associations between physical/sexual violence, 
self-efficacy, and sexual health (Table 5). A study conducted by Sales and colleagues (2008),92 
which did not limit its definition of forced vaginal or anal intercourse to intimate relationships, 
found that this history of sexual violence is associated with condom nonuse among African 
American adolescent females (15-21 years).92 History of sexual violence was also associated 
with lower sexual communication self-efficacy and being more fearful of condom use 
negotiation; these factors mediated the relationship between sexual violence and condom 
nonuse.92  
Two studies limited their definitions of violence to dating relationships. A study 
conducted by Beadnell and colleagues (2000)93 of adult women at risk for STIs and HIV found 
that while physically abused women had higher HIV/STD risk scores and lower self-efficacy to 
negotiate male condom usage with partner compared to non-abused and emotionally-only abused 
women, they were no more likely to have poor condom usage. Wingood and DiClemente 
(1997)43 conducted a study of young adult African American women (18-29 years) similarly 
found that physical abuse was associated with both perpetrated and perceived consequences of 
negotiating condom use, including experiencing verbal abuse or threats of physical abuse and 
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perceiving risk of verbal abuse or physical abuse. However, unlike Beadnell’s findings,93 
physically abused women in Wingood and DiClemente’s study were more likely to report not 
using condoms at all or less frequently compared to women who were not recently physically 
abused.43 Physical abuse assessment and referent time periods were similar between these two 
studies. 
SCT provides a theoretical framework through which to consider the impact of males 
perpetrating violence and controlling their female partners’ reproductive health. While there is 
not substantial evidence, findings suggest that the association between IPV and sexual health 
behaviors and outcomes may be mediated, in part, through sexual self-efficacy. As previously 
reviewed, there are both actual and perceived consequences to negotiating condom use in 
abusive relationships.14,40,43,64 Self-efficacy is key to overcoming these very real barriers to safer 
sex practices. Overall, these findings suggest that, at least among adolescent and young adult 
women, self-efficacy plays a role in maintaining sexual and reproductive health through 
influencing safer sex behaviors; evidence is most compelling for inconsistent condom usage, 
increasing vulnerability to unwanted pregnancies and STIs. Sexual self-efficacy should be 
further explored as an explanatory factor in the relationship between IPV and sexual health 
behaviors and outcomes. Elucidating temporality of these associations using a longitudinal 
design could provide potential targets for decreasing the health burden caused by IPV, especially 
in young, vulnerable populations. 
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Table 5. Key studies on the association between intimate partner violence, sexual self-efficacy, and sexual health outcomes 
Author 
(Year) 
Population and 
sample size 
Measures Results Comments 
Sales 
et al. 
(2008)92  
Sexually active 
African 
Americans 
females (15-21 
years) survey 
data from an 
HIV-prevention 
intervention 
(n=715) 
Sexual violence: “has anyone ever forced you to 1) have 
vaginal sex when you didn’t want to, 2) have anal sex when 
you didn’t want to? 
Fear of consequences of condom negotiation: 7 item scale, 
“I have been worried that if I talked about using condoms, 
my boyfriend or sex partner would…” leave me,  threaten to 
hit me, hit me, etc. 
Sexual communication self-efficacy: 6 item scale, including 
“with a sex partner, how hard is it for you to ask how many 
sex partners he has had?” and “with a sex partner, how hard 
is it for you to ask if he would use a condom?” 
Sexual health: condom use at last intercourse, use in the last 
60 days (# of times used condoms / # of sex acts; 100% = 
consistent condom users, >50% high, =<50% low) 
• Lifetime sexual violence 26% 
• Less likely to use condoms at last 
intercourse (31.2% vs 46.9%, p<.001), 
using condoms consistently in the past 60 
days (13.9% vs 29.1%, p<.001), being 
categorized as frequent condom users 
(35.4% vs 53.6%, p<.001) 
• More fearful of condom use negotiation 
(mean=11.1 vs 9.9, p<.001) 
• Lower sexual communication self-efficacy 
(mean=19.9 vs 21.0, p<.0o1) 
• Sexual communication self-efficacy and 
fear of condom use negotiation 
consequences mediated the relationship 
between sexual violence and all three 
sexual behavior outcomes  
• Only captures severe sexual 
violence 
• Violence not specified to 
partner 
• Mediation analysis, used 
Sobel test 
• Biases in who would enroll 
in an HIV-prevention 
intervention 
• Cross-sectional 
Beadnel
l 
et al. 
(2000)93 
Women with 
steady partner(s) 
in the past 4 
months were 
selected from 
202 women 
enrolled in a 
safer-sex 
intervention 
study; 18 years 
of age or older 
and at risk for 
HIV/STIs 
(n=167) 
IPV: Your steady partner…1)said 
things that hurt you or made you feel bad about yourself, 
2)tried to control where you go, who you see and/or what you 
do, 3)threatened to physically hurt you, 4)hit, pushed, 
shoved, kicked, slapped, or in any other way physically hurt 
you’ 
Sexual health:  STD/HIV Risk score: relative power for 
decision making, unwanted sex, partner non-monogamy, self-
efficacy for condom use, self-efficacy for female barrier 
method use 
Self-efficacy measured on 7 point Likert scale from “not at 
all likely” to “very likely” 
• No abuse: 42% 
• Emotional only: 42% 
• Physical/emotional: 16% 
• Physical abuse had highest STD/HIV 
risk score (p<.01) and lowest self-efficacy 
to get partner to use condoms score 
(p<.01), but not more likely to report using 
male condoms half the time or less 
• Cross-sectional 
• Women were specifically 
screened into a safer-sex 
intervention study 
• Excluded those whose lives 
were not “stable enough” for 
a four month intervention 
Wingoo
d & 
DiClem
ente 
Heterosexually-
active African 
American 
women, 18-29 
IPV: “During the past 3 months, has your primary partner 
physically abused you (i.e., slapped or hit you)?” 
Sexual health: 
Condom use: # of times used condoms / # of episodes of 
• 17.6% reported physical abuse in past 3 
months 
• Physically abused women more likely to 
report not using condoms at all (71.4% 
• Unstable confidence 
intervals, but the trends 
across the items indicates 
strong associations 
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( 
1997)43 
years (n=165) intercourse 
Consequences of condom negotiation: “When you asked 
your primary partner to use condoms, how often were you… 
1) verbally abused, 2) threatened with physical abuse, 3) 
threatened with abandonment 
Perceived consequences of negotiating condom use: “How 
often have you been scared to talk with your primary partner 
about using condoms because you thought your primary 
partner might be… 1) physically abusive, 2) verbally abusive, 
3) threatened to physically abuse you, 4) threaten to abandon 
you 
vs 42.6%, p=0.04) or less frequently 
(22% vs 44%, p=0.04) compared to not 
recently abused women 
Consequences of negotiating condom use 
PR (95% CI) 
• Verbal abuse PR=4.2 (1.9-9.3) 
• Threaten physical abuse PR=9.2(2.5-
34.6) 
• Threaten abandonment PR=3.7 (1.1-
13.0) 
Perceived consequences of negotiating 
condom use 
• Physical abuse PR=6.5 (2.3-18.9) 
• Verbal abuse PR=4.1 (1.7-9.7) 
• Threaten physical abuse PR=3.3 (1.1-9.6) 
• Threaten abandonment PR=3.7 (1.1-
13.0) 
 
• No actual measurement of 
self-efficacy, have to infer 
from real and perceived 
consequences to condom 
use negotiation 
• Cross-sectional 
• Results not adjusted for any 
demographics or other 
possible confounders 
• Accuracy of condom use 
measure? 
Table 5 Continued 
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2.5. CONCLUSIONS 
Male partner perpetrated IPV and RC have been associated with poor reproductive and sexual 
health outcomes among adolescent and young adult women, who have are disproportionately 
affected by IPV/RC.  
While primary prevention is critical (i.e., preventing men from perpetrating such 
violence), it is clear that secondary prevention efforts are necessary to reduce negative 
consequences of such victimization. Key gaps in IPV and reproductive/sexual health research 
ned to be addressed to guide intervention efforts. 
First, the pathways between IPV/RC and sexual and reproductive health outcomes should 
be elucidated to identify potential targets for intervention. SCT provides one possible 
explanatory factor: sexual self-efficacy, which has been identified in the literature as an attribute 
that is related to both IPV and sexual health behaviors and outcomes in a few independent 
studies. While some of the studies that have attempted to integrate IPV exposure, sexual self-
efficacy, and sexual health outcomes have had inconsistent findings, the literature overall 
suggests that sexual self-efficacy may partially explain the poorer health outcomes among some 
victims of IPV. As sexual self-efficacy has been shown to be modifiable in interventions 
specifically for sexual and reproductive health,94-96  it is imperative to determine its place in the 
pathway to inform future interventions (Aim 1).  
Second, research indicates that women with negative male partner influence may use 
contraceptives differently, both in initiation, continuation, and compliance. Both IPV and RC are 
related to contraceptive nonuse, regardless of the woman’s preferences. Long-acting reversible 
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contraceptives (LARC) are available and recommended for adolescent and young adult women, 
but are greatly underutilized in this younger age group.58 The more commonly used methods, 
such as oral contraceptives, have high rates of discontinuation or poor use.58,66 Non-LARC, 
female-controlled methods, including oral contraceptives and hormonal rings, have the potential 
to be tampered with by male partners.97,98 Condoms are less likely to be used by abusive male 
partners,43,61-63 thus precluding use of a contraceptive method and the best protection against 
STIs. Identifying how male partners influence contraceptive use patterns can inform both 
clinicians and public health practices to provide the optimal care and programs for affected 
women (Aim 2). 
Finally, research on IPV and its associated sequelae is particularly difficult. Unlike many 
medical conditions, there are no biomarkers or concrete “tell-tale” signs. Assessment requires a 
combination of asking the right questions (whether it be a written survey, interviewer, or 
healthcare provider), the woman identifying behaviors she has experienced as unhealthy or 
abusive, and the woman being able and willing to disclose. Current research is limited by studies 
that mainly use exclusively self-report or exclusively medical record data. Given the 
considerable energy and expense that can be associated with collecting medical record data, it 
should be ascertained how much this substantially adds to the reliability of IPV assessment. 
Possible biases should be explored with each method. Ultimately the goal is to identify best 
methods for IPV research moving forward (Aim 3). 
In summary, IPV is highly prevalent in the U.S. and has been associated with many poor 
reproductive and sexual health outcomes, including unintended pregnancies and STIs. Condom 
nonuse, fear of negotiation, and other contraceptive nonuse are mechanisms linked to IPV 
exposure, and reflect the multiple ways that male partners can influence women’s reproductive 
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and sexual decision making. RC, a phenomenon characterized by male partners trying to control 
their female partners’ reproductive choices, is gaining attention for how it may explain some of 
the associations observed in the literature. Elucidating protective factors, mechanisms, patterns, 
and best methodologies for this research will inform secondary prevention efforts to reduce the 
sequelae associated with IPV/RC.  
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3. ADDRESSING REPRODUCTIVE COERCION IN HEALTH SETTINGS STUDY
The Addressing Reproductive Coercion in Health Settings study (ARCHES) (PIs: Miller and 
Silverman; NIH grant # R01HD064407) is a cluster randomized controlled trial (RCT) to test the 
effectiveness of a clinician-delivered brief intervention on IPV and RC during routine clinical 
visits compared to standard of care in twenty-four family planning clinics in Western 
Pennsylvania. The goal of the intervention is universal education and reducing risks and 
associated consequences of IPV, RC, and unintended pregnancies. Women ages 16-29 years who 
were receiving care at participating family planning clinics for any reason, could speak English 
or Spanish, and were able to give consent were eligible to participate. A total of 3687 women 
agreed to participate; current analyses will be restricted to women 16-19 years of age (n=850) 
and 20-24 years of age (n=1,396) at enrollment who reported a history of heterosexual sex for a 
total of 2,246 women. The division of age groups into 16-19 and 20-24 years is consistent with 
the National Survey of Family Growth reporting on contraceptive use and pregnancy data.34  
Women completed surveys at baseline (prior to clinical encounter), at a four month 
follow-up (T2), and a twelve month follow-up (T3) (Figure 1). Women self-reported 
demographics, recent and lifetime experiences of IPV, recent RC, self-efficacy (general, condom 
negotiation, use of harm reduction behaviors), recognition of sexual and reproductive coercion, 
lifetime and recent history of pregnancy, unintended pregnancy, and abortions, and for baseline 
only, future pregnancy intention (see Appendix for key measures used in the current study, Aims 
 
 
41 
 
1 and 3) . Women also completed an exit survey immediately following their clinical visit to 
assess intervention fidelity. All surveys were taken using an audio computer-assisted self-
interview program (ACASI) on laptops, which participants took in private rooms of the clinics. 
Participants 18 years and older completed the follow-up surveys in person on the laptops or via 
telephone or online; 16 and 17 year old participants completed the follow-up surveys in person 
on the laptops or via telephone. Medical record data were abstracted for one year pre-enrollment 
through eighteen months post-enrollment for thirty months total. HIPPA waivers were healthcare 
organization-specific, so data were available at all sites for women who moved between clinics 
within a given organization; information on healthcare received at outside institutions was not 
collected.  
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Figure 1. Addressing Reproductive Coercion in Health Settings Flow Chart 
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4. NATIONAL SURVEY OF FAMILY GROWTH
The National Survey of Family Growth (NSFG) is a nationally representative survey of men and 
women 15-44 years of age in the United States.9 It is commissioned by the Centers for Disease 
Control and Prevention’s National Center for Health Statistics. The purpose of the survey is to 
create nationally representative estimates for pregnancy and pregnancy risk, medical care 
associated with pregnancy, factors affecting household structure (e.g., marriage, divorce), 
adoption, father involvement behaviors, and attitudes about marriage, childbearing, and sex. The 
latest complete cycle was conducted in 2006-2010 among 12,279 women and 10,403 men. Data 
are collected through administration of a one-time cross-sectional survey (e.g., no longitudinal 
follow-up).  
For this study, the relevant data are the extensive contraceptive use histories that women 
self-report and span up to the past four years, including types of methods used on a month-by-
month basis and reasons for discontinuation. Of the 12,279 women interviewed, 4,382 were 
between the ages of 15-24 years. After excluding those who had never had sex with a male, were 
pregnant, post-partum, or trying to become pregnant, and those who could not become pregnant, 
2,541 women remained eligible for analysis (15-19 years, n=972; 20-24 years, 1,569). 
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5.1  ABSTRACT 
Context: Partner violence (including physical and sexual violence and reproductive coercion) is 
associated with unintended pregnancy and sexually transmitted infection (STI). Condom 
negotiation self-efficacy (CNSE) may mediate this relationship among adolescent and young 
adult women. 
Methods: A randomized controlled trial with one year follow-up was conducted in family 
planning clinics to test an intervention on reducing partner violence and its adverse consequences 
(age range: 16-24 years, n=2,246). Adolescent (16-19 years; n=850) and young adult women 
(20-24 years; n=1,396) reported on partner violence, CNSE, unintended pregnancy, and any STI 
at enrollment, four months, and twelve months follow-up. Mixed models were used in a 
secondary data analysis to test associations between partner violence and unintended 
pregnancy/any STI, adjusting for race/ethnicity and intervention arm. The Sobel test of 
mediation was conducted using a SAS macro developed for binary outcomes to measure the 
indirect effects of CNSE. 
Results: Recent (past three month) partner violence was reported by 11.5% of adolescents and 
8.9% of young adults at baseline. Adolescents reporting partner violence had significantly lower 
CNSE (β=-2.04, 95% CI -0.65, -0.143) and 5% higher odds of unintended pregnancy 
(AOR=1.05, 95% CI 1.00,1.10) over follow-up. Among adolescents, CNSE mediated the 
relationship between partner violence and unintended pregnancy (Sobel test <.05), but not STI 
diagnosis. Among young adults, partner violence was associated with decreased self-efficacy 
(β=-0.157 [-0.211,-0.104]) and higher odds of unintended pregnancy (AOR=1.05 [1.00,1.09]). 
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Condom negotiation self-efficacy only mediated the relationship between partner violence and 
unintended pregnancy (Sobel test p<.01). 
Conclusions: Partner violence is associated with decreased condom negotiation self-efficacy 
among both adolescents and young adults; this partially mediates the relationship between 
partner violence and unintended pregnancy, but not STI. This finding indicates that women with 
abusive partners may not be able to successfully negotiate condom use, despite having the self-
efficacy to do so. STI prevention may require additional strategies beyond increasing condom 
negotiation skills.   
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5.2  BACKGROUND 
Unintended pregnancy and sexually transmitted infections (STI) are disproportionately prevalent 
among adolescent and young adult females in the U.S. Three-quarters (77%) of births to 15-19 
year olds and half (50%) of births to 20-24 year olds result from unintended pregnancy.34 STIs 
are also common in these age groups, representing half of new cases,99 and may lead to pelvic 
inflammatory disease, infertility, and ectopic pregnancies.46 Physical and sexual intimate partner 
violence (IPV) and reproductive coercion (RC; attempts to control pregnancy and pregnancy 
outcomes of female partners) are also widespread among adolescent and young adult women.7,11 
Understanding the mechanisms linking IPV/RC to reproductive outcomes among adolescent and 
young adult women is needed to target intervention efforts that aim to reduce unintended 
pregnancy, STI, as well as IPV/RC. 
The literature on IPV/RC clearly links these experiences to poor reproductive and sexual 
health outcomes such as unintended pregnancy and STI. Young women who have experienced 
IPV, RC, or both, have higher odds of unintended pregnancy7,11 and greater difficulty obtaining 
and using contraception.41 These women also are more likely to report a history of STI47-49 and 
test positive for a STI.48 One pathway by which partner violence can lead to unintended 
pregnancy and STI is via condom nonuse, as young women who experience IPV use condoms 
less frequently6,40,47,48,52,61,65 and have greater barriers to condom use.14,40,43,64   
Condom use is part of sexual self-efficacy, an important factor in understanding these 
associations. Self-efficacy is a construct that captures a person’s beliefs that he or she can 
accomplish certain tasks and goals. In terms of sexual health, this can include self-efficacy to 
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negotiate condom use, refuse unwanted sex, and use contraception. Sexual self-efficacy (SSE) 
has been associated with condom use,87,88,100 non-condom contraceptive use,88 and not engaging 
in unprotected intercourse88-90,101 in adolescent and young adult women. Thus, SSE is a 
promising avenue for exploration as a possible mechanism linking IPC/RC with unintended 
pregnancies and STI, and may ultimately provide an opportunity for prevention and intervention 
in girls. 
To further our understanding of the causal pathway between IPV/RC and unintended 
pregnancy/STI, we have identified condom negotiation self-efficacy (CNSE) as a possible 
mediator in the relationship between partner violence and unintended pregnancy/STI among 
adolescent and young adult women. CNSE is particularly relevant because condom usage 
requires a male partner’s cooperation, and is also a protection against STI. Additionally, as the 
literature has shown that partner violence is associated with greater barriers and perceived 
consequences to condom negotiation,14,40,43,64 we hypothesized that CNSE would be directly 
affected by IPV/RC. 
Research indicates that sexual102 and emotional103 self-efficacy naturally increase with 
age over adolescence (i.e., without outside intervention). SSE has also been shown to be higher 
among sexually active adolescents,104 and sexual self-concept increases with increasing sexual 
experiences.105 The associations between sexual self-efficacy and behavior may also vary by age. 
For example, in one cross-sectional study of SSE, birth control self-efficacy was associated with 
contraceptive use among girls in 10th and 11th grade, but not among younger girls in 7th-9th 
grades.106 In another study, communication with a partner about contraception prior to sex was 
associated with using effectiveness contraception among 13-20 year olds, but not 21-25 year 
olds.107 Further, a review found that early pubertal timing and relatively more advanced pubertal 
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status were associated with more sexual acts and riskier sexual behaviors among adolescents.108 
As SSE develops across adolescence and as girls become more experienced, age should be taken 
into consideration in assessments of IPV/RC, CNSE, and reproductive health. 
This study uses a large dataset from 24 rural and urban family planning clinics to test 
associations among age, CSNE, IPV/RC, and reproductive health.  For this study, we first 
hypothesized that CNSE would be lower among adolescent women (16-19 years) compared to 
young adult women (20-24). Second, we hypothesized that among these two age groups, women 
who experience recent IPV or RC would have lower CNSE, more unintended pregnancy, and 
more STI compared to women who have not recently experienced IPV or RC. Finally, we 
hypothesized that CNSE would mediate the association between IPV/RC and unintended 
pregnancy/STI among both age groups. 
5.3 METHODS 
5.3.1 Study design and sample 
The present study uses data that were collected as part of the Addressing Reproductive Coercion 
in Health Settings (ARCHES) Study (R01HD064407: Miller & Silverman), a cluster randomized 
controlled trial to test a clinician-delivered brief intervention on RC/IPV. The study protocol has 
been described in detail elsewhere.109  Briefly, this study was conducted in 24 Western 
Pennsylvanian family planning clinics and enrolled women 16-29 years of age. Women were 
approached by research staff when they arrived for their clinical care appointments. Interested 
women were consented and completed the baseline survey in a private area of the clinic. Parental 
 
 
50 
 
consent was waived for minors, as they were receiving confidential services. A total of 3,687 
women enrolled at baseline (of which 2,697 were ages 16-24).  
Surveys at baseline, a four-month follow-up, and twelve-month follow-up were 
completed using ACASI software on a laptop computer at the clinic. Participants could also 
complete the follow-up surveys via an online survey (ages 18 and older) or telephone (all ages). 
The University of Pittsburgh Institutional Review Board approved all study procedures.  A 
federal Certificate of Confidentiality was obtained to protect participant confidentiality. The 
present study is restricted to women who reported heterosexual sexual intercourse and provided 
complete information for all key measures on a survey. The heterosexual sex restriction is due to 
survey design on the pertinent questions for the parent study. Those missing values on 
demographics were assigned the modal response for modeling. The final sample size for this 
study is n=2,246 (16-19 years, n=850; 20-24 years, n=1,396).  
5.3.2 Key measures 
Past three month intimate partner violence (IPV) was assessed using three items modified from 
the CTS-2110 and Sexual Experiences Survey111: one for physical IPV and two for sexual IPV. 
Reproductive coercion (RC) was assessed using ten items developed by Miller and colleagues 
for use in adolescent and young adult populations.7,11 Items included “tried to force or pressure 
you to become pregnant” and “taken off the condom while you were having sex, so you would 
get pregnant.” For both the IPV and RC scales, answering yes to one or more items was coded as 
positive for IPV or RC, respectively. Women who endorsed any of these IPV or RC items were 
identified as having experienced recent partner violence. These measures were collected at 
baseline, the four month follow-up, and the twelve month follow-up. 
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The reproductive health outcome unintended pregnancy was assessed at the twelve 
month follow-up using seven items on pregnancy desire and planning from the National Survey 
of Family Growth.9 Lifetime history of unintended pregnancy was assessed at baseline with one 
item: “How many times have you been pregnant when you didn't want to be?” The reproductive 
health outcome STI diagnosis was assessed in all surveys by querying women as to whether they 
had been told by a doctor or other health care professional that they had an STD, with listed 
examples: “ chlamydia, gonorrhea (also known as the clap), syphilis, herpes, genital warts, 
Hepatitis B, and HIV”; the baseline survey used referent time periods of lifetime and past three 
months and the follow-up surveys specified past three months only. 
Condom negotiation self-efficacy (CNSE) was assessed at baseline, four-month follow-
up, and twelve-month follow-up using five items that assessed participants’ confidence to 
request condom use and refuse unprotected sex (e.g., “I feel confident in my ability to suggest 
using condoms with a new partner” and “If my partner didn't want to use a condom during sex, I 
feel confident in my ability to refuse to have sex”). Items were adapted from the 28 item 
Condom Use Self-Efficacy Scale that was originally created for young adults (college 
students).112 Response options were on a 5 point Likert scale from “strongly agree” to “strongly 
disagree” and the mean score was calculated.  
5.3.3 Analysis 
Chi square analyses assessed whether demographic characteristics differed by age group 
(Adolescent versus Young Adult) and by inclusion status in the present analysis (included in 
final analytic sample versus excluded).  Chi square and linear regression tests were used to 
determine if partner violence and CNSE, respectively, varied by age group. To conduct the 
mediation analysis, a SAS macro created by Jasti and colleagues113 was used. This macro is 
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based on work by MacKinnon and Dwyer,114 who described standardizing the coefficients from 
logistic regression models to allow for a Sobel test to be used in cases of binary outcomes or 
mediators. Using this macro, adjusted linear and logistic regression mixed models were used to 
determine 1) the effect of partner violence on CNSE; 2) the effect of partner violence on 
unintended pregnancy and STI and; 3) the combined effects of partner violence and CNSE on 
unintended pregnancy and STI. A Sobel test was then conducted with the linear regression 
coefficients and standardized logistic regression coefficients. Use of the mixed models allowed 
for recent partner violence, CNSE, and unintended pregnancy/STI outcomes to be time-varying 
(i.e., all data points collected on these measures were used). Race/ethnicity and intervention arm 
were adjusted for in all models. 
Survey data analysis methods were used to account for the clustering of patients within 
clinics, with clinic clusters being the unit of randomization for the parent RCT. All analyses were 
conducted using SAS version 9.496 and with a significance level set at alpha=0.05.  
5.4 RESULTS 
5.4.1 Participant characteristics 
Almost two-thirds (62.2%) of the participants were 20-24 years of age (Table 6). Participants 
were predominantly non-Hispanic White (79.4%) with no racial/ethnic differences by age. The 
majority of women (71.6%) were receiving care at clinics designated as rural by the Bureau of 
Commerce,115 with no differences by age. Adolescents were more likely to report recent partner 
violence (19.8%) compared to young adults (14.5%). Conversely, young adults were more likely 
to report a past-year unintended pregnancy (15.0%) and ever being diagnosed with an STI 
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(31.5%) compared to adolescent women (9.7% and 20.0%, respectively). Mean CNSE (SE) was 
4.45 (0.01) on a 1 to 5 scale, with no difference by age group.  
 Participants 16-24 years who were excluded from the present analysis had a higher 
proportion of adolescents (55.2%) compared to those who were included (37.9%, p=0.01) and 
were more likely to report being single or dating more than one person at baseline (58.3 vs. 
31.3%, p<.01). Participants who were excluded did not differ from included participants on 
baseline partner violence, past-year unintended pregnancy, or lifetime STI diagnosis.  
To account for possible confounding, age group was also tested for difference in baseline 
partner violence and CNSE while adjusting for race/ethnicity and intervention status. Age group 
was still significantly associated with reporting recent partner violence, with adolescents having 
a 46% higher odds of reporting victimization compared to young adult women (AOR=1.46, 95% 
CI 1.11-1.92) in the adjusted model. Age group was not associated with baseline CNSE (β=-
0.016, p=0.56) in the adjusted model.  
5.4.2 Incident partner violence and reproductive/sexual health outcomes during follow-up 
Recent partner violence was reported by 11.5% of adolescents at the four-month follow-up and 
11.9% at the twelve month follow-up (Table 7). Among young adults, 8.9% reported recent 
partner violence at four-month follow-up and 8.6% at the twelve month follow-up. Recent STI 
diagnosis was reported by 5.2% of adolescents at four month follow-up and 3.8% at the twelve 
month follow-up. Among young adult women, STI diagnosis was reported by 4.0% and 3.5% at 
the four and twelve month follow-ups, respectively. Past-year unintended pregnancy was 
reported at the twelve month follow-up only by 16.6% of adolescents and 16.6% of young adults.  
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5.4.3 Mediation analysis 
Among adolescents, recent partner violence was associated with significantly lower 
CNSE (β = -2.04, 95% CI -0.65, -0.143) and unintended pregnancy (AOR=1.05, 95% CI 1.00-
1.10) (Table 8). CNSE mediated the effect of partner violence on unintended pregnancy (indirect 
effect=0.004, Sobel test p<.05), with higher CNSE associated with reduced odds of reporting an 
unintended pregnancy (AOR=0.96, 95% CI 0.93-0.99). Of the total effect of partner violence on 
unintended pregnancy, 18.9% is estimated to be due to mediation through CNSE. Partner 
violence was also associated with increased odds of reporting an STI diagnosis during follow-up 
(AOR=1.06, 95% CI 1.03-1.08), but CNSE did not mediate this effect. 
Among young adult women, partner violence was associated with decreased CNSE (β = -
0.157, 95% CI -0.211, -0.104). Partner violence was associated with unintended pregnancy 
(AOR=1.05, 95% CI 1.00-1.09), with its effect mediated by CNSE (indirect effect=0.004, 
p<.01). Higher CNSE was associated with lower odds of reporting an unintended pregnancy 
(AOR=0.95, 95% CI 0.93-0.98), with this mediation accounting for 24.8% of the total effect of 
partner violence. Recent partner violence was associated with higher odds of reporting an STI 
diagnosis (AOR=1.05, 95% CI 1.03-1.07), but this effect was not mediated by CNSE.  
5.5 DISCUSSION 
This study represents an important first step in determining the role that partner violence plays in 
the reproductive health problems in women in primarily rural settings. These findings indicate 
that partner violence is associated with lower condom negotiation self-efficacy, increased 
unintended pregnancy, and increased STI diagnosis among adolescent and young adult women. 
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Furthermore, condom negotiation self-efficacy (CNSE) mediated the relationship between 
partner violence and unintended pregnancy, but not partner violence and STI diagnosis.  
Contrary to our hypothesis and the literature on SSE in general, CNSE did not vary by 
age group. Partner violence was more prevalent among adolescent compared to young adult 
women, and it was associated with lower CNSE as hypothesized. This finding is consistent with 
previous studies. For example, Wingood and DiClemente found that physical IPV was associated 
with perceived and perpetrated consequences to condom use negotiation, such as experiencing 
verbal abuse or threats of physical abuse or fearing risk of abuse.43 Beadnell and colleagues 
similarly showed that physically abused women had lower CNSE compared to non-abused 
women.93  
Higher CNSE was associated with lower odds of unintended pregnancy, but surprisingly, 
was not associated with STI diagnosis. It is possible that women with higher CNSE are also 
more likely to use other forms of contraception that provide more reliable protection against 
unintended pregnancy, such as the longer acting reversible contraception options of intrauterine 
devices and hormonal implants. However, these methods were only used by 2.4% and 5.1% of 
non-pregnant adolescents and young adult women, respectively, at study enrollment. For STI, 
however, since women report multiple barriers to condom negotiation and use with abusive 
partners,14,40,43,64 CNSE may not translate into actual condom use.  In other words, a woman's 
CNSE may not necessarily influence her partner's condom use behaviors. Alternatively, STI are 
often asymptomatic, which may lead to reduced diagnosis and reporting in this sample.  
This sample of adolescent and young adult women had a high lifetime prevalence of STI 
diagnosis and unintended pregnancy at baseline. Many have already experienced negative 
reproductive health outcomes, consistent with the higher prevalence of lifetime unintended 
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pregnancy and STI in more urban family planning populations. While partner violence and 
CNSE were shown to impact odds of unintended pregnancy and STI, effect sizes were small in 
comparison to past sexual health experiences. Targeted interventions with younger adolescent 
females to promote healthy relationships, practice condom negotiation skills, and increase 
contraceptive use prior to initiating sexual activity may be the most effective in reducing these 
negative sexual health outcomes.  Additionally, these findings suggest that clinic-based brief 
counseling interventions for young women with prior histories of unintended pregnancy may 
benefit from strengthening condom negotiation skills in addition to promoting female 
contraception. Prevention of STI, however, may require additional strategies beyond a focus on 
increasing condom negotiation skills.  
As the majority of prior studies examining the effect of partner violence on unintended 
pregnancy, STI, and sexual self-efficacy have been cross-sectional, a major important strength of 
this study is the longitudinal design which allows us to demonstrate temporal relationships. 
Allowing for time-varying measures of partner violence, CNSE, and the outcomes (STI at two 
timepoints, unintended pregnancy at one), better captures the changes in CNSE and partner 
experiences that we would expect in a young woman’s yearlong timespan. 
However, there are a few limitations to note. Due to missing data, women excluded from 
the analysis were younger and less likely to be in stable relationships at baseline. However, as 
there were no differences in baseline reports of partner violence, unintended pregnancy, or 
lifetime STI diagnosis, we do not believe that the missing data exclusions substantially impacted 
our results.  As women were recruited from primarily rural family planning clinics in western 
Pennsylvania, findings may not be representative of the general adolescent and young adult 
female population. Specifically, our study should be replicated in more racially and ethnically 
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diverse populations, including urban dwelling women. Nonetheless, this study represents women 
in more rural areas who may have different reproductive health needs and barriers compared to 
more urban settings. Finally, the estimated effects of partner violence and CNSE were small but 
significant. This is likely due to the strong predictability of unintended pregnancy and STI 
history with future cases; thus the majority of the cases have been “explained” before 
considering partner violence and CNSE. This underscores the need to target younger women 
before sexual activity begins to prevent first cases of unintended pregnancy and STI.  
In a sample of sexually active adolescent and young adult women, partner violence was 
associated with increased odds of unintended pregnancy and STI diagnosis within a one year 
period. Condom negotiation self-efficacy mediated nearly one-fifth (18.9%) and one-quarter 
(24.8%) of the total effect of partner violence on unintended pregnancy in adolescents and young 
adult women, respectively, although there was no evidence of a mediation effect with STI 
diagnosis. Future interventions in this population should focus on increasing condom negotiation 
self-efficacy, as sexual self-efficacy is modifiable. Such programs should target younger women 
prior to unintended pregnancy and acquisition of STI. 
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5.6  TABLES 
 
Table 6. Participant characteristics at baseline (n=2,246) 
 Total 
(n = 2,246) 
Adolescent 
(n = 850) 
Young adult 
(n = 1,396) 
Wald log 
linear χ2 p 
value b 
 % (n) a % (n) a % (n) a  
Total  37.9 (821) 62.2 (1,344)  
Race/ethnicity    0.688 
     Black/African-
American 
14.2 (318) 14.8 (126) 13.8 (192)  
     White 79.4 (1,783) 78.4 (666) 80.0 (1,117)  
     Multiracial or Other 6.1 (136) 6.1 (52) 6.0 (84)  
Relationship status    0.002 
     Single/dating more 
than one person 
31.3 (702) 30.5 (259) 31.7 (443)  
     Dating one person/In a 
serious relationship 
63.9 (1,435) 67.7 (575) 61.6 (860)  
     Married 4.1 (92) 0.8 (7) 6.1 (85)  
Clinic cluster region c    0.119 
   Rural 71.6 (1,607) 74.4 (632) 69.8 (975)  
   Urban 9.7 (218) 8.8 (75) 10.2 (143)  
   Both rural and urban 
sites 
18.7 (421) 16.8 (143) 19.9 (278)  
Recent partner violence 16.5 (370) 19.8 (168) 14.5 (202) 0.015 
Past year unintended 
pregnancy 
13.0 (292) 9.7 (82) 15.0 (210) 0.001 
Lifetime STI diagnosis 27.1 (609) 20.0 (170) 31.5 (439) 0.0003 
 100.0 100.0 100.0  
Condom negotiation 
self-efficacy, mean (SE) 
4.45 (0.01) 4.44 (0.02) 4.46 (0.02) 0.683 d 
a Percentages may not sum to 100 due to small amounts of missing date and rounding 
b χ2 p values are from Wald tests adjusted for clustered survey design 
c Clinics were assigned to clusters based on share providers for the parent study, allowing for 
clusters with both urban and rural sites 
d SAS®96 PROC SURVEYREG was used to obtain p values for continuous variables and 
adjusted for clustered survey design 
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Table 7. Key outcomes at 4- and 12-month follow-up phases 
 T2 (4 month follow-up) T3 (12 month follow-up) 
 Adolescents 
(n=611) 
% (n) 
Young adults 
(n=1,047) 
% (n) 
Adolescents 
(n=679) 
% (n) 
Young adults 
(n=1,086) 
% (n) 
Partner violence 11.5 (70) 8.9 (93) 11.9 (81) 8.6 (93) 
Past year unintended 
pregnancy 
--- --- 16.6 (113) 16.6 (180) 
Recent (past three month) 
STI diagnosis 
5.2 (32) 4.0 (42) 3.8 (26) 3.5 (38) 
 100.0 100.0 100.0 100.0 
Condom negotiation self-
efficacy, mean (SE) 
4.45 (0.03) 4.46 (0.01) 4.54 (0.02) 4.55 (0.02) 
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Table 8. Mediation analysis 
Sexual Health Outcomes 
Adolescents Young adults 
CNSE 
Estimate (95% CI)a 
CNSE 
Estimate (95% CI)a 
Model 1: Partner violence 
predicting CNSE 
-0.204 (-0.265, -0.143)*** -0.157 (-0.211, -0.104)*** 
   Partner violence 
Unintended 
pregnancy 
AOR (95% CI)a 
STI diagnosis 
AOR (95% CI)a 
Unintended 
pregnancy 
AOR (95% CI)a 
STI diagnosis 
AOR (95% CI)a 
Model 2: Partner violence 
predicting outcome 
   Partner violence 1.05 (1.00 - 1.10)* 1.06 (1.03 - 1.08)*** 1.05 (1.00 - 1.09)* 1.05 (1.03 - 1.07)*** 
Model 3: Partner violence and 
CNSE predicting outcome 
   Partner violence 1.04 (0.99 - 1.09) 1.05 (1.03 - 1.08)*** 1.03 (0.99 - 1.08) 1.05 (1.02 - 1.07)*** 
   CNSE 0.96 (0.93 - 0.99)* 0.99 (0.98 - 1.01) 0.95 (0.93 - 0.98)** 0.99 (0.98 – 1.00) 
Mediation Analysis 
   Indirect effect, (SE) 0.004 (0.002)* 0.001 (0.001) 0.004 (0.001)** 0.001 (0.001) 
   Percent of total effect that is 
mediated, % 
18.9% 3.2% 24.8% 4.6% 
a All models adjusted for race/ethnicity and intervention status 
*p<.05. **p<.01. ***p<.001.
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6.1  ABSTRACT 
Objective: To assess partner influence on contraceptive use in a nationally representative sample 
of U.S. adolescent and young adult women. 
Study Design: We examined data from 2,541 sexually active women (ages 15-19, n=972; ages 
20-24 years, n=1,569) (U.S. National Survey of Family Growth). Lifetime experiences of male 
partner influences (partner influence of contraception termination, partner wants a child and 
woman does not) were assessed as the main predictors. Primary outcomes were current and past-
year use of female-controlled contraceptives (FCC) (oral contraception, intrauterine devices, 
implants, injectables, patches, and rings) as well as past-year FCC nonuse, number of methods 
used, and discontinuation. Generalized estimating equations were used to estimate prevalence 
ratios (current FCC use) and risk ratios (past-year nonuse, number of methods, and 
discontinuation associated with partner influence. 
Results: Two in 5 adolescents (42.6%) and half of adult women were currently using an FCC. 
Partner influence was associated with greater FCC use in young adults (prevalence ratio = 1.24, 
95% CI 1.19-1.30) but adolescence moderated this effect (interaction term PR=0.66 [0.53-0.84]). 
Adolescents had used and discontinued more FCC methods in the past year as compared to 
young adults, regardless of partner influence (risk ratio = 1.29 [1.07-1.57] and RR=1.88 [1.44-
2.44], respectively). 
Conclusions: Partner influence may be related to current and past contraceptive use. In 
particular, partner influence is associated with suboptimal current and past-year contraceptive 
use among adolescents. Clinicians should directly discuss partner influences on contraceptive use 
63 
and address barriers, including partners’ interference with and influence over contraceptive 
decision making. Offering a range of method options that partners are least likely to interfere 
with will support autonomy in vulnerable populations.  
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6.2  BACKGROUND 
Of the sexually experienced women in the U.S., almost all (99%) have used some type of 
contraception at least once.58 However, lapses in contraceptive use are common. Nationally, 
11.0% of women 15-44 years old at risk for unintended pregnancy reported not currently using 
any method.58 Adolescent and young adult women are particularly likely to go without 
contraception; 14.8% of 15-19 year olds and 18.0% of 20-24 year olds report not currently using 
any method.58   Thus, nearly all sexually-experienced women have used some form of 
contraception, but lapses in coverage are common among adolescent girls and young adults, 
leaving a substantial minority of them at risk of unintended pregnancy. 
Among 15-24 year old women who do use contraception, a large proportion choose less 
effective methods. From national data, 29.4% report relying on condoms only and 49.5% use 
oral contraceptives (birth control pills) as their most effective forms of contraception.58 These 
methods are associated with 18% and 9% failure rates in the first year of typical use, 
respectively.116 A compounding problem with contraceptive nonuse is that even after a female 
starts a given method, chances of discontinuation or suboptimal compliant use are high. During a 
one-year study in which 16-24 year old women started or switched to oral contraception, only 
35% reported that they were still using oral contraception at the twelve-month follow-up and 
30% were not using any contraception66; perceived risk for pregnancy was not associated with 
continued contraceptive use at follow-up.66 Another study found that 15.9% of 15-19 year olds 
and 16.4% of 20-24 year olds who had ever used a contraceptive were currently sporadic 
users.117  Therefore, most adolescent and young adult women who do use contraception rely on 
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less effective methods and a significant proportion of them discontinue or use these methods 
inconsistently. 
Given these patterns, there has been considerable effort to identify factors related to 
contraceptive nonuse, discontinuation, and less effective use. Relationship and partner 
characteristics that appear to influence contraceptive use range from length of time and living 
situation with a current partner118-120 to severe partner abuse – including physical and sexual 
intimate partner violence21,41,71,121 and reproductive coercion 121(male partner attempts to 
impregnate a female against her wishes or to control the outcome of a pregnancy3).  Factors 
associated with poor contraceptive use include relationship conflict,119,122,123 perceptions that a 
partner does not want to use contraception,124 believing that unprotected sex has partner benefits 
(e.g., is a sign of love ),123,124 power differences within the relationship,125 and comparatively 
older partners.126 Conversely, factors that are associated with better contraceptive use include 
relationship intimacy,122,127 greater commitment to a partner,122 communicating with a sexual 
partner about contraception,107,127-130 shared sexual decision-making,131 partner involvement in 
contraceptive choice and use,131 and perception that the partner wants to use condoms or other 
contraception.130,132,133 Overall, this research indicates that open communication, mutual positive 
attitudes towards contraceptive use, and power-equitable relationships contribute to a woman’s 
consistent contraceptive use. 
 The body of work to date on relationship dynamics associated with contraceptive 
methods, non-use, and discontinuation of use has several limitations. Studies have largely 
assessed contraceptive use at last intercourse or within a single short period of time (e.g., thirty 
days) or measure contraceptive use as condom use alone or in conjunction with other methods 
(“any contraceptive use”). Defining partner influence on contraceptive use over time as opposed 
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to during a single time point should provide a better classified predictor  in models of unintended 
pregnancy. Further, female controlled contraception (FCC; non-condom, non-barrier 
contraceptives, including intrauterine devices (IUDs), hormonal implants, injectables, oral 
contraceptives, hormonal patches, and intravaginal rings) provide options for women that are 
largely under their own control and do not require partner knowledge or cooperation. FCCs 
(especially longer activing reversible contraceptives) offer women greater reproductive 
autonomy when faced with more severe forms of partner influence, including intimate partner 
violence and reproductive coercion (pregnancy coercion, birth control sabotage, and interference 
with contraceptive use7,11,41) .Therefore, this current study aims to assess partner influences’ on 
FCC over a twelve month period to elucidate such influence might impact unintended pregnancy 
risk.  
For this study, we hypothesize that women who report partner influence on contraception 
will be less likely to currently use an FCC method, report more months of FCC nonuse, use more 
types of FCC methods, and discontinue more types of FCC methods in the past year compared to 
women who do not report partners influencing their contraceptive decision-making. 
6.3 METHODS 
6.3.1 Study design and sample 
We utilized National Survey of Family Growth (NSFG) data from the 2006-2010 cycle. The 
NSFG is a nationally representative survey on reproductive health topics conducted regularly in 
the United States. Details on the sampling frame and survey items have been previously 
published.134,135 Briefly, 12,279 women and 10,403 men between the ages of 15-44 years were 
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interviewed in person from June 2006 to July 2010. Strata and cluster identification account for 
the sampling design and weighting is used to account for nonresponse and oversampling of pre-
specified subgroups. 
The focus group of this study is adolescent and young adult women (ages 15-24) who 
reported any history of heterosexual sex and are capable of becoming pregnant. Of the 4,382 
age-eligible women, those who never had sex with a male (n=1,462), were currently pregnant 
(n= 201), immediately postpartum (n=51), were trying to become pregnant (n=85), or reported 
that they were sterile (n=42), were excluded. The remaining sample was 2,541 women eligible 
for analysis (ages 15-19 years, n=972; ages 20-24 years, n=1,569). Given that the different 
determinant variables were asked of only certain groups (described below), sample size varied by 
the predictor assessed.  
6.3.2 Key measures 
Partner influence was identified in two distinct manners. Women who reported ever having 
stopped using oral contraceptives, condoms, the Depo-Provera or Lunelle injectable, or 
contraceptive patch due to dissatisfaction were queried for discontinuation reasons (n=861). 
Those who selected ‘my partner did not like it’ were identified as positive for partner influenced 
contraception termination. Women who were married or cohabitating reported their perception 
of their partner’s desire for (a/nother) child (n=615). Women who reported that they do not want 
or were unsure about wanting (a/nother) child but that their partner did want (a/nother) child 
were identified as positive for discordant pregnancy intentions.  
Complete contraceptive use histories for the three to four years prior to the survey 
interview were collected on a month-by-month basis. However, this current analysis is restricted 
to contraceptive use in the past year. Per NSFG guidelines,135 the most effective method reported 
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in a month is identified as the primary method.  For all outcomes, female-controlled 
contraception (FCC) was defined as reporting use of the following methods: ‘birth control pills,’ 
‘Depo-Provera, injectables,’ ‘hormonal implant (Norplant or Implanon),’ ‘IUD, coil, or loop,’ 
‘emergency contraception,’ ‘Lunelle injectable (monthly shot),’ ‘contraceptive patch,’ or 
‘vaginal contraceptive ring.’ Women who were using any of the FCC methods during the month 
of the interview were coded as positive for current use of FCC. Past-year months of FCC nonuse 
was calculated by summing the number of months in which the participant did not report using at 
least one FCC in the past twelve months. Past-year number of FCC methods used was calculated 
by summing the FCC method types that participants reported using in the past twelve months. 
Past-year FCC discontinuation was calculated by assessing the number of methods used that 
were reported in the past year that were not being used in the month of interview (e.g., a woman 
who only used oral contraceptives in the past year but was not using them during the month of 
interview was identified as discontinuing one FCC method).  
Variables that were considered as covariates were respondent’s race/ethnicity, household 
income relative to the poverty level, and gravidity. 
6.3.3 Analysis 
Demographic and sexual/reproductive history characteristics were assessed. The number of 
women who were asked and endorsed each of the partner influence characteristics were 
identified and reported. Contraceptive use at the beginning of the time period (12 months prior to 
interview) and at the time of the interview were assessed using the most effective method in the 
month and reported here separately for adolescents (15-19 years) and young adults (20-24 years). 
Generalized estimating equation (GEE) models that accounted for survey design were 
used to assess partner influence, adolescent age group, and the interaction between partner 
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influence and age on FCC use outcomes. Due to the high prevalence of current FCC use, a log-
binomial GEE model136 was used to estimate the prevalence ratios associated with partner 
influence. Past-year FCC use outcomes were assessed using GEE models with Poisson 
distributions. To account for differential time at risk for those women who had sexual intercourse 
for the first time within the past year, the number of months between the first sexual intercourse 
and the date of the survey was calculated (“time active”) and top-coded at 12 months (eligible for 
entire time period). For past-year months of FCC nonuse, this value was used as an offset term to 
identify the time period at risk (0-12 months). For past-year number of FCC methods used and 
past-year FCC discontinuation, this time active term was categorized as 0-5 months, 6-11 
months, and 12 or more months and included as a covariate. Race/ethnicity, poverty level, and 
gravidity were also included as covariates in all models.  
All analyses accounted for the multi-level survey design with respondent weighting using 
SAS v9.4.96 All percentages presented are weighted per NSFG recommendations.134,135 
Significance was set at alpha=0.05. 
6.4 RESULTS 
6.4.1 Participant characteristics 
Of the women who were eligible for the present analysis, 35.5% were 15-19 years old and 64.5% 
were 20-24 years old (Table 9). A majority of women (59.4%) identified as non-Hispanic White, 
with the remaining identifying as non-Hispanic Black (14.3%), Hispanic (16.6%), and non-
Hispanic other or multiracial (9.7%). Half (51.0%) were currently attending school and 22.6% 
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lived with both biological parents. Over a quarter of the women (27.9%) reported household 
incomes below the poverty line. Most women had no history of pregnancy (68.2%). 
6.4.2 Partner influence characteristics 
Of the 861 women who reported having ever stopped using oral contraceptives, condoms, Depo-
Provera or Lunelle injectable, or the contraceptive patch due to dissatisfaction, 60 (6.9%) 
reported that their partners did not like that method (adolescents: 6.9%, young adults: 6.9%; 
Table 10). Of the 615 women who reported their married or cohabitating partner’s pregnancy 
intentions, 33 (4.0%) reported that while the women did not want (a/nother) child, their partner 
did (7.6% and 3.4% of adolescents and young adults, respectively).  
6.4.3 Contraceptive use 
Twelve months prior to the interview, 1 in 3 adolescents (31.5%) and 1 in 4 young adults 
(26.4%) were not using any contraceptive method to prevent pregnancy, while 1 in 4 adolescents 
(24.2%) and 1 in 5 young adults (19.5%) relied on condoms for pregnancy prevention (Table 
11). Of the FCC, oral contraception was most commonly reported (26.7% of adolescents and 
37.0% of young adults). Adolescents also reported using the Depo-Provera injectable (7.9%), but 
no other FCC methods were endorsed by at least 5% of adolescents or young adult women. Of 
the non-condom and non-FCC methods available, withdrawal was reported by 1 in 20 women 
(4.4% and 6.1% for adolescents and young adults, respectively), but other methods were rarely 
used as the primary contraceptive. 
At the time of the interview, 35.0% of adolescents and 23.2% of young adult women 
were currently not using anything to prevent pregnancy, while 17.7% and 22.2%, respectively, 
were using condoms. Of the FCC, oral contraception was the primary method (28.7% and 35.4% 
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for adolescents and young adults, respectively), with the Depo-Provera injectable for adolescents 
(7.5%) being the only other FCC method reported by more than 5% of the sample. Withdrawal 
was endorsed by 1 in 20 women (6.0% and 5.4% for adolescent and young adults, respectively). 
6.4.4 Partner influence and contraceptive use  
Current FCC use was reported by 42.6% of adolescents and 49.9% of young adult women (Table 
12). Adolescents reported more months of past-year FCC nonuse compared to young adult 
women (7.4 months versus 6.2 months, respectively). Of the adolescent women, 24.0% reported 
no months of FCC use and 43.4% reported using an FCC every month in the past year. One in 
three young adult women (35.1%) did not report any FCC methods, while 38.6% reported using 
an FCC every month in the past year. 
The total number of FCC methods used in the past year was similar for the age groups 
and averaged 0.67 methods; 40.1% of women used no FCC methods in the past year, while 6.8% 
used two or three methods. The number of FCC methods discontinued was also similar for the 
age groups and averaged 0.18 methods, with the vast majority (83.5%) not discontinuing any 
FCC methods.  
Current FCC use. Current FCC use was more prevalent among women who reported 
partner influence on contraception termination compared to those who did not report this 
influence (adjusted prevalence ratio=1.24, 95% CI 1.19-1.30). There was no main effect of age 
group, but there was a significant interaction between partner influence and adolescence, such 
that current FCC use was less prevalent among adolescents reporting partner influence 
(PRadj=0.66 [ 0.53-0.83]). Current FCC use was less prevalent among Black women compared to 
White (PRadj=0.79 [0.73-0.84]), with no other racial differences.  
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Current FCC use was not more prevalent among those reporting discordant pregnancy 
intentions with partner (PRadj=1.14 [0.97-1.35]) or adolescence (PRadj=0.91 [0.75-1.12]). The 
interaction term was omitted due to model nonconvergence. 
Past-year months of FCC nonuse. The main effects of partner influence on contraception 
termination and adolescence main effects were not significantly associated with past-year 
months of FCC nonuse. However, an interaction between the two terms indicated a marginally 
higher risk for FCC nonuse among adolescents reporting partner influence (RRadj=1.49 [0.93-
2.37]). Black race was also associated with higher risk for FCC nonuse (RRadj=1.58 [1.33-1.88]). 
Discordant pregnancy intentions with partner, adolescence, and the interaction term were 
not associated with past-year months of FCC nonuse. Black race was the only significant 
predictor of FCC nonuse in this model (RRadj=1.25 [1.05-1.48]). 
Past-year number of FCC methods used. In models assessing past-year number of FCC 
methods, partner influence on contraception termination (RRadj=1.26 [1.16-1.38]) and 
adolescence (RRadj=1.29 [1.07-1.57]) were associated with greater number of methods, but there 
was no significant interaction between the two terms. Black race was associated with fewer FCC 
methods (RRadj=0.54 [0.48-0.62]). 
Discordant pregnancy intentions with partner were marginally associated with more FCC 
methods (RRadj=1.24 [0.98-1.55]), but adolescence and adolescents experiencing partner 
influence were not. Black and Multiracial or Other races reported fewer FCC methods 
(RRadj=0.76 [0.59-0.99] and RRadj=0.73 [0.62-0.85], respectively), while those of Hispanic 
ethnicity reported more methods (RRadj=1.25 [1.08-1.43]).  
Past-year number of FCC methods discontinued. Models for past-year FCC 
discontinuation showed no significant relationship with partner influence on contraception 
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termination, but there was a significant relationship between adolescence and FCC 
discontinuation (RRadj=1.88 [1.44-2.44]). There was no significant interaction between these two 
terms (RRadj=0.76 [0.28-2.06]). Women identifying as Black discontinued fewer FCC methods 
(RRadj=0.56 [0.44-0.72]). 
 Discordant pregnancy intentions, adolescence, and the interaction term between the two 
were not associated with the number of FCC methods discontinued. Black women reported fewer 
methods discontinued (RRadj=0.55 [0.37-0.83]), while Hispanic women reported discontinuing 
more FCC methods (RRadj=2.02 [1.41-2.90]). 
6.5 DISCUSSION 
The present study uses nationally representative data to assess partner influence on adolescent 
and young adult women’s contraceptive habits over time, particularly methods that are under 
greater female control. Findings indicate that, contrary to our hypothesis regarding current use of 
FCC, past partner influence on contraception termination was significantly associated with 
greater current use of FCC. It was also associated with past-year number of FCC methods, as 
hypothesized. Adolescents, including those with and without experiences of partner influence, 
were less likely to be currently using a method and had more method switching overall. 
Adolescent and young adult women from minority racial and ethnic groups reported less 
optimal contraceptive behaviors compared to White peers. Young Black women had less current 
FCC use, more months of nonuse, and fewer methods used overall in the past year, while 
Hispanic women used and discontinued more FCC methods in the past year. These findings 
persisted despite controlling for poverty status and are consistent with other studies conducted in 
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the U.S. that show racial and ethnic disparities in contraceptive use. For example, one study 
showed that of women who did not want any (more) children, those who identified as a racial 
minority were over half as likely to not use contraceptive at last intercourse compared to non-
Hispanic White women, after accounting for demographic, socioeconomic, reproductive 
characteristics, and healthcare access and utilization.137 Another study on women 18-29 years of 
age found that almost half of Black women (45%) and over one-third of Hispanic women (38%) 
were not currently using a contraceptive method, compared to one-quarter (24%) of White 
women.138 Further, of those women who were using contraception, use of oral contraception or 
other hormonal methods was lower among Black (29%) and Hispanic (30%) women compared 
to White women (59%).138 The associations between race and ethnicity with contraceptive use 
were not mediated by differences in attitudes on contraception, pregnancy, fertility, and 
childbearing across race after adjusting for participant characteristics.138 Given that neither 
access nor knowledge and attitudes can explain these disparities in contraceptive use and thus 
unintended pregnancy risk, public health programs must go beyond these first-tier factors and 
explore the greater context in which young women are making these contraceptive decisions and 
facing possible barriers to use – such as partner violence and coercion.  
Overall, these adolescent and young adult women, when using contraception at all, 
primarily rely on condoms and oral contraception for pregnancy prevention. Other FCC, 
particularly long acting reversible contraception (LARC) such as the IUD and hormonal implant, 
are vastly underutilized in this population, thus exposing younger women to risk for unintended 
pregnancy. Oral contraceptive use is the major component of the relatively high FCC prevalence 
(48.0% overall), but there are dramatic differences in usage patterns. The present data suggest 
that there are primarily two categories of users: those who always use an FCC and those who do 
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not use FCC at all. While we do not know the consistency and reliability of use for the consistent 
users (i.e., “perfect use” versus “typical use”), it appears that the greatest need is for women who 
never use FCC to be targeted for contraceptive counseling, to facilitate their transition to FCC 
use. 
For the purposes of this work, we grouped the various female-controlled methods of 
contraception together. However, qualitative work indicates that there are actually varying 
degrees of control across methods. For example, oral contraceptive use can be sabotaged through 
destroying the pills (e.g., washing them down sink) or preventing a woman from going to the 
clinic or pharmacy to pick up the pills.3,97,98 IUD use, on the other hand, can be made “invisible” 
by cutting strings, providing years of protection from pregnancy without a partner’s knowledge. 
In addition to varying levels of control, different contraceptive methods are not equally effective. 
Of women with “typical use” of oral contraceptives, 9% on average will become pregnant within 
the first year; of the two IUD types assessed, 0.2-0.8% of women on average experience a 
pregnancy that first year.116 Thus, women may choose (or be counseled on) the methods that 
offer the greatest protection with least vulnerability to partner influence or tampering. 
Encouragingly, a study found that after providing adolescent females with information on these 
methods (such as LARC) and the option to choose a method at no cost, 72% of the adolescent 
girls chose a LARC method.139 Thus, we would expect favorable results with increased 
education about these options for young patients. 
There are several limitations to this study. We combined contraceptive methods with 
varying levels of control, invisibility, and effectiveness into a collective “FCC use.” However, as 
our hypothesis is that women experiencing partner influence will try a number of different 
methods to find the right balance of their lives, the grouping of these female-controlled methods 
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is appropriate. These data are self-reported by women at a single point in time; thus, recall bias is 
possible when considering reports for contraceptive use up to four years prior to the interview. 
To address this issue, contraceptive data were restricted to the twelve months prior to the 
interview. Additionally, the NSFG provides nationally representative data; as most studies on 
unintended pregnancy and partner violence are conducted in family planning or 
obstetrician/gynecology offices, use of these data are an important move forward in this field. 
Finally, the items selected to represent partner influence were not asked of all respondents, but 
rather were contingent on other conditions (e.g., had to be married or cohabitating to be asked 
about their perceptions of their partners’ pregnancy intentions). However, the items used may 
represent subtler partner behaviors that ultimately influence contraceptive use.  
The present study assessed current contraceptive use and partner influence on female 
controlled contraception – contraception that can be used without a male partner’s explicit 
knowledge and cooperation. Almost half of adolescent and young adult women currently use 
these female controlled methods, but few are choosing the LARC methods that are most 
effective at protecting against pregnancy. Young adult women may be using female controlled 
contraception to cope with past partner influence, but adolescent women reporting partner 
influence had worse contraceptive use. Future work should focus on those groups vulnerable to 
partner violence and influence, such as family planning clinic patients, racial/ethnic minorities, 
those of low socioeconomic status, and, as illustrated in this study, adolescent girls.  
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6.6 TABLES 
Table 9. Participant characteristics 
Characteristic Total Sample 
(n=2,552) 
Weighted % a 
Demographics 
Age Group 
   15-17 years 12.7 
   18-19 years 22.8 
   20-22 years 37.2 
   23-24 years 27.2 
Race/ethnicity 
   Non-Hispanic White 59.4 
   Non-Hispanic Black 14.3 
   Non-Hispanic Other or Multiracial 9.7 
   Hispanic 16.6 
Born in the U.S. 
   Yes 90.7 
   No 9.3 
Currently in school 
   Yes 51.0 
   No 49.0 
Currently living with both biological parents 
   Yes 22.6 
   No 77.4 
Household poverty level 
   0-99% 27.9 
   100-199% 26.1 
   200-299% 18.1 
   ≥ 300% 28.0 
Went without health insurance coverage at all in 
past year 
   Yes 31.2 
   No 68.8 
Sexual and reproductive history 
Gravidity 
   None 68.2 
   One 17.5 
   Two or more 14.3 
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Lifetime number of male sexual partners 
   One 28.9 
   Two or three 26.9 
   Four to six 24.2 
   Seven or more 20.0 
a Percentages are weighted to account for survey sampling design 
Table 9 Continued 
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Table 10. Partner influence characteristics 
Determinants Qualification Number 
Eligible 
Number Endorsed 
% of those eligible a 
Partner influenced 
contraception 
termination 
Respondents who reported ever 
having stopped using oral 
contraceptives, condoms, the 
Depo-Provera or Lunelle 
injectable, or contraceptive 
patch due to dissatisfaction 
861 60 (6.9%) 
   Adolescents 252 16 (6.9%) 
   Young adults 609 44 (6.9%) 
Discordant 
pregnancy 
intentions with 
partner 
Respondents who were married 
or cohabitating with their 
partner 
615 33 (4.0%) 
   Adolescents 107 6 (7.6%) 
   Young adults 508 27 (3.4%) 
a Percentages are weighted to account for survey sampling design
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Table 11. Most effective contraceptive women reported using twelve months prior to interview and month of interview 
Contraceptive methodsa Adolescents (15-19 years) Young adults (20-24 years) 
Twelve months prior to 
interview 
% (95% CI)b 
Month of interview 
% (95% CI)b 
Twelve months prior 
to interview 
% (95% CI)b 
Month of interview 
% (95% CI)b 
No method used 31.5 (26.5, 36.4) 35.0 (31.1, 38.9) 26.4 (22.8, 30.0) 23.2 (20.1, 26.3) 
Condom 24.2 (19.7, 28.7) 17.7 (14.4, 21.0) 19.5 (16.6, 22.4) 22.2 (19.3, 25.1) 
Female Controlled Contraception 
   Birth control pills 26.7 (21.9, 31.5) 28.7 (24.7, 32.7) 37.0 (32.9, 41.1) 35.4 (31.5, 39.4) 
   Depo-Provera, injectables 7.9 (4.9, 10.9) 7.3 (5.1, 9.4) 4.6 (3.2, 6.0) 4.0 (2.5, 5.4) 
   Hormonal implant (Norplant or 
Implanon) 
0.35 (0.00, 0.82) 0.26 (0.00, 0.60) 0.49 (0.00, 1.00) 0.65 (0.07, 1.2) 
   IUD, coil, or loop 0.98 (0.05, 1.9) 1.8 (0.58, 3.1) 2.3 (1.3, 3.3) 4.5 (3.1, 5.9) 
   Lunelle injectable (monthly 
shot) 
0 (0) 0 (0) 0 (0) 0.27 (0.00, 0.65) 
   Contraceptive patch 1.6 (0.54, 2.6) 1.4 (0.28, 2.4) 0.73 (0.28, 1.2) 0.42 (0.14, 0.70) 
   Vaginal contraceptive ring 1.8 (0.35, 3.3) 1.7 (0.43, 2.9) 1.8 (0.92, 2.8) 3.0 (1.8, 4.3) 
Other 
   Withdrawal, pulling out 4.4 (2.2, 6.6) 6.0 (3.5, 8.5) 6.1 (4.3, 8.0) 5.4 (3.9, 7.0) 
a The following methods were not listed because they were endorsed by less than 1% of women at both timepoints and were not one of 
the pre-specified FCC methods of interest: safe period by temperature of cervical mucus test, diaphragm, foam, jelly or cream, 
suppository insert, partner was sterile but not from a vasectomy,   rhythm or safe period by calendar, female condom or vaginal pouch, 
emergency contraception, partner’s vasectomy, and other method 
b Percentages are weighted to account for survey sampling design 
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Table 12. Associations of male partner influence with contraceptive use 
Current FCC use Past-year FCC use 
Current FCC use 
% (95% CI)a 
Months of FCC nonuse 
Mean (95% CI)a 
Number of FCC methods 
Mean (95% CI)a 
FCC discontinuation 
Mean (95% CI)a 
Total 47.3 (44.4-50.2) 6.6 (6.2-7.0) 0.67 (0.63-0.71) 0.18 (0.15-0.20) 
   Adolescents (15-19 years) 42.6 (37.8-47.3) 7.4 (6.9-7.9) 0.64 (0.59-0.70) 0.20 (0.16-0.23) 
   Young adults (20-24 years) 49.9 (46.5-53.4) 6.2 (5.7-6.6) 0.68 (0.64-0.73) 0.17 (0.14-0.19) 
Prevalence Ratio 
(95% CI) 
Risk Ratio 
(95% CI) 
Risk Ratio 
(95% CI) 
Risk Ratio 
(95% CI) 
Model 1: Partner influenced 
contraception termination 
   Partner influence 1.24 (1.19-1.30) 0.87 (0.57-1.32) 1.26 (1.16-1.38) 1.16 (0.91-1.46) 
   Adolescence 1.02 (0.91-1.15) 1.01 (0.85-1.20) 1.29 (1.07-1.57) 1.88 (1.44-2.44) 
   Partner influence * 
Adolescence 
0.66 (0.53-0.83) 1.49 (0.93-2.37) 0.60 (0.23-1.59) 0.76 (0.28-2.06) 
   Race/ethnicity 
     White ---Reference Group--- ---Reference Group--- ---Reference Group--- ---Reference Group--- 
     Black 0.79 (0.73-0.84) 1.58 (1.33-1.88) 0.54 (0.48-0.62) 0.56 (0.44-0.72) 
     Hispanic 1.02 (0.94-1.10) 1.18 (0.95-1.46) 1.06 (0.95-1.19) 1.02 (0.76-1.36) 
     Multiracial and Other 0.85 (0.69-1.05) 1.35 (0.94-1.94) 0.78 (0.58-1.06) 0.97 (0.71-1.33) 
   Household income below the 
poverty level 
0.98 (0.87-1.11) 1.00 (0.88-1.13) 1.07 (0.97-1.18) 1.27 (1.07-1.51) 
   History of pregnancy 1.05 (0.94-1.16) 1.04 (0.86-1.24) 1.00 (0.90-1.08) 0.83 (0.64-1.09) 
   Time since first intercourse 
     0-5 months 1.02 (0.60-1.74) N/Ab 1.34 (1.06-1.69) 1.74 (1.08-2.83) 
     6-11 months 1.22 (1.12-1.33) N/A b 1.82 (1.41-2.35) 2.27 (1.36-3.81) 
     12 months or more ---Reference Group--- ---Reference Group--- ---Reference Group--- ---Reference Group--- 
Model 2: Discordant 
pregnancy intentions 
   Partner influence 1.14 (0.97-1.35) 0.96 (0.73-1.28) 1.24 (0.98-1.55) 1.72 (0.71-4.16) 
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   Adolescent 0.91 (0.75-1.12) 1.17 (0.80-1.72) 1.04 (0.76-1.41) 1.51 (0.998-2.29) 
   Partner influence * 
Adolescent 
N/Ac 1.29 (0.76-2.19) 1.14 (0.73-1.78) 0.33 (0.02-4.43) 
   Race/ethnicity 
     White ---Reference Group--- ---Reference Group--- ---Reference Group--- ---Reference Group--- 
     Black 0.87 (0.75-1.01) 1.25 (1.05-1.48) 0.76 (0.59-0.99) 0.55 (0.37-0.83) 
     Hispanic 1.04 (0.96-1.13) 1.00 (0.84-1.18) 1.25 (1.08-1.43) 2.02 (1.41-2.90) 
     Multiracial and Other 0.88 (0.75-1.01) 1.22 (0.93-1.59) 0.73 (0.62-0.85) 0.52 (0.17-1.57) 
   Household income below the 
poverty level 
1.08 (1.06-1.10) 0.94 (0.86-1.04) 1.10 (0.98-1.24) 0.92 (0.49-1.74) 
   History of pregnancy 0.95 (0.81-1.12) 1.23 (0.99-1.54) 0.87 (0.75-1.01) 0.74 (0.51-1.08) 
   Time since first intercourse 
     0-5 months 1.36 (1.22-1.52) N/A b 1.30 (1.23-1.37) 0.72 (0.20-2.62) 
     6-11 months 0.87 (0.65-1.17) N/Ab 0.95 (0.49-1.84) 1.00 (0.26-3.87) 
     12 months or more ---Reference Group--- ---Reference Group--- ---Reference Group--- ---Reference Group--- 
a Percentages are weighted to account for survey sampling design 
b Not applicable because time since first intercourse was used as an offset term in this model 
c The interaction term had to be excluded from this model due to nonconvergence. 
Table 12 Continued 
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7.1  ABSTRACT 
Objective: To assess concordance of self-report and medical record data for sexually transmitted 
infections (STI) and pregnancy, and factors associated with discordant reporting. 
Methods: Young women (16-24 years, n=2,203) reported on recent STI, past-year pregnancy, 
intimate partner violence (IPV), and reproductive coercion (RC) in a family planning clinic 
survey and granted access to their medical records. We evaluated the overlap of case 
ascertainment by data source and constructed multinomial mixed models to identify factors 
associated with discordant reporting. 
Results: STI were more likely to be self-reported but not found in the medical record among 
African-American women compared to White women (AOR=3.01, 95% CI 2.01-4.50) and 
women who reported recent IPV or RC, compared to women without these experiences 
(AOR=1.82 [1.16-2.87] and AOR=2.82 [1.74-4.59], respectively). This same pattern was 
observed for pregnancy for African American women (AOR=1.84 [1.22-2.77]), women who 
experienced IPV (AOR=1.85 [1.39-2.46]) or RC (AOR=2.22 [1.57-3.13]), and women who were 
intending future pregnancy at baseline (AOR=2.10 [1.37-3.21]).  
Conclusions: Self-report detected more cases of STI and pregnancy compared to medical record 
data. Factors associated with discordant reporting may lead to underestimation of these sexual 
health outcomes. Using multiple follow-up surveys with shorter recall periods to events may 
provide more accurate information. 
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7.2  BACKGROUND 
Sexually transmitted infections (STI) and unintended pregnancy are widespread public health 
problems, particularly for adolescent and young adult women.34,140  While a substantial body of 
research has led to effective interventions to reduce STI and unintended pregnancy in this 
population, the optimal methods for measuring these sexual and reproductive health outcomes 
remain controversial. While biological samples are the gold standard, where resources are 
limited, researchers rely on medical records as well as self-reports on surveys.  Research 
indicates there are considerable discrepancies in self-reports over time and in self-reports 
compared to medical record data,75,76,141 creating the potential for biased results. 
Several studies have found that, specifically for adolescents, sexual health information 
such as STI is underreported with self-report on a survey compared to medical records and in-
person interviews, which are typically conducted in adolescent health clinics or as part of 
national surveys.75,76 One study found that although self-reported data resulted in lower 
prevalence estimates of chlamydia and gonorrhea compared to composites from medical records 
and health department reports, the kappa scores of agreement were within an acceptable range 
(0.67 to 0.80).141 Discordance in reporting could go both ways – reported by self-report and not 
in the medical record or in the medical record but not reported on a survey.  Understanding the 
extent of this discordance and any potential predictors of such discordance in reporting is needed 
to improve the methodologic rigor of adolescent and young adult sexual health research. 
While collecting biological samples for STI and pregnancy testing are certainly the gold 
standard for measuring sexual health outcomes, many clinic studies rely on self-report on 
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surveys as well as secondary data from clinic and health department records.  As extracting 
medical record data can be expensive and time consuming, estimating the extent of discordance 
between self-report and medical record information would be helpful to guide sexual health 
researchers on the value of adding chart extraction to a study.  Similarly, identifying factors 
associated with discordant reporting may also highlight potential underestimation and biases.   
Past research has identified several demographic factors associated with discordant 
reporting. Discordant reporting is more likely among younger adolescents compared to older 
adolescents for sexual behaviors such as occurrence and age of first vaginal sex.77,142,143 In one 
study, survey respondents were asked “How honest were you in what you said about your sexual 
behavior?”; fewer middle school girls reported that their answers were ‘just as much as I have’ 
compared to high school girls (70.3% vs. 82.8%, p≤.001),144  indicating that developmental stage 
and age differences should be considered when assessing adolescent reporting of health 
behaviors . Longitudinal studies that use self-report at multiple timepoints have shown that 
among adolescents and young adults, African-American females have higher odds of rescinding 
reports of engaging in sexual intercourse142 and, along with Hispanic females, lower adjusted 
odds of consistently reporting age at first sex143 compared to their White peers.  Finally, since 
unintended pregnancy is associated with public insurance or no insurance compared to private 
insurance,145,146 we could expect differences in reporting by clinic funding (e.g., accepts patients 
with public insurance or provides low-cost healthcare for the uninsured).  
Demographic factors alone, however, do not fully account for discordant reporting and 
variations in discordant reporting across groups of adolescents. Family planning clinic clients 
represent a particularly vulnerable group of adolescent and young adults. No studies have 
examined the extend of discordant reporting between self-report on self-administered surveys 
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and medical record data among this clinic population at elevated risk for STI and unintended 
pregnancy. Free-standing family planning clinics tend to serve younger women who do not have 
a consistent medical home and women who are seeking confidential services for a variety of 
reasons, often in socially disadvantaged communities. Not only is the prevalence of STI and 
unintended pregnancy higher in this population than in the general population, women seeking 
care in family planning clinic settings tend to be younger and to report higher prevalence of 
intimate partner violence (IPV) and reproductive coercion (RC; a male partner’s attempts to 
impregnate a female against her wishes or control the outcome of a pregnancy).7,8,10,11,147  Of 
particular interest in terms of discordance in sexual health outcome reporting is the possible role 
of IPV and RC.  IPV and RC have been shown to be associated with STI47-49,148 and unintended 
pregnancy7,11,37,41,148 as well as greater healthcare seeking, including for STI testing, pregnancy 
testing, and emergency contraception.10,147,149,150 As IPV is often not disclosed to healthcare 
providers because of fear, not feeling ready to disclose (i.e. haven’t reached the “turning 
point”151), shame and embarrassment, seeing the violence as a personal issue, and fear of their 
children being removed,152-154 health outcomes associated with or a direct result of abuse may 
similarly not be disclosed via self-report. If that is the case, studies that utilize self-reported data 
only for STI or pregnancy may underestimate the associations with abuse. Conversely, if patients 
are accessing healthcare at multiple places, medical record data accessed at one organization or 
facility may be incomplete.  These and related factors may contribute to discordant reporting in 
the family planning clinic population, which have not been explored in the adolescent sexual and 
reproductive health literature to date.   
We first assessed the concordance between self-report and medical record data for STI 
and pregnancy diagnoses over a 24 month period in adolescent and young adult women attending 
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family planning clinics. We then determined whether age differences (adolescent versus young 
adult), race/ethnicity, or pregnancy intention predicted discordant reporting. Finally, we assessed 
whether IPV and RC are associated with discordant reporting of STI and pregnancy. 
7.3  METHODS 
7.3.1 Study design and sample 
The present study uses data that were collected as part of a large cluster randomized controlled 
trial in family planning clinic settings (R01HD064407: Miller & Silverman), designed to test a 
clinician-delivered brief intervention to reduce RC/IPV and associated negative health 
consequences. The study protocol is described in detail elsewhere.109 Briefly, this study was 
conducted in 24 Western Pennsylvanian family planning clinics and enrolled women 16-29 years 
of age. Women at the clinic for care were approached by research staff when they arrived. 
Interested women were consented and completed the baseline survey in a private area of the 
clinic. Parental consent was waived for minors, as they were receiving confidential services. 
Participants were asked to sign medical record authorization forms to allow the study team to 
abstract their medical record data, but this authorization was not required for study participation. 
A total of 3,687 women enrolled at baseline (of which 2,697 were ages 16-24). 
Surveys were conducted at baseline, four months, and twelve months, using a laptop 
computer in the clinic with ACASI software. For follow-up surveys only, participants could also 
complete the surveys via telephone (all ages) or online (18 years and older). Trained research 
assistants abstracted medical record data from one year prior to study enrollment through 18 
months post-enrollment, for thirty months total. A detailed protocol was developed to ensure 
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uniform abstraction and weekly quality checks were conducted.  A total of 3,590 records (97% 
of baseline sample) were abstracted. The University of Pittsburgh Institutional Review Board 
approved all study procedures.  A federal Certificate of Confidentiality was obtained to protect 
participant confidentiality.  
Participants from the parent study were excluded from the present analysis for the 
following criteria: being 25 or older (n=990), not ever having sex or only having sex with 
women (baseline, n=125; four-month follow-up, n=99; twelve-month follow-up, n=82), not 
having sex in the past three months (n=209, n=752, and n=210, respectively), missing 
information on key survey measures for the present study (n=99, n=100, and n=162, 
respectively), and missing medical record data (n=61, n=17, and n=198, respectively). These 
exclusions were made on a by-timepoint basis, such that women who had to be excluded at one 
visit would remain in the sample for the other timepoints for which they were eligible.  The final 
total eligible sample was 2,203 women at baseline, 1,121 at the four-month follow-up, and 1,613 
at the twelve-month follow-up (see Figure 2).  
7.3.2 Key measures 
Intimate partner violence (IPV) was assessed on surveys using one item for physical IPV110 and 
two items for sexual IPV (with and without the use of force)111 modified for the parent study.109 
Reproductive coercion (RC) was reported on surveys using ten items developed for use in young 
female populations7; example items are “tried to force or pressure you to become pregnant” and 
“taken off the condom while you were having sex, so you would get pregnant.” For both the IPV 
and RC items, answering yes to one or more items was coded as positive for IPV or RC, 
respectively. Recent (past three month) IPV and RC were assessed at baseline, four-mouth 
follow-up, and twelve-month follow-up; lifetime IPV was collected at baseline only. 
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 Past-year pregnancy was reported on the baseline and the twelve-month follow-up 
surveys. At baseline, the item was “How many times have you been pregnant in the past 12 
months?” This question was modified for the twelve-month follow-up to “How many times have 
you been pregnant in the past 12 months – including miscarriages and abortions?” At both 
timepoints, response options were “I have not been pregnant in the past 12 months,” “once,” and 
“twice or more.” Pregnancy intention was assessed on the baseline survey by asking “are you 
planning on becoming pregnant in the next 12 months?” (5 point Likert scale of definitely no to 
definitely yes) and “How much do you agree with the following statement: I would like to get 
pregnant in the next year” (5 point Likert scale of strongly agree to strongly disagree). Those 
who reported planning to become pregnant (definitely yes or yes) or that they would like to get 
pregnant (strongly agree or agree) in the next year were coded as being positive for pregnancy 
intention.  
 Sexually transmitted infections (STI) were reported using a single item on surveys at 
baseline, four-month follow-up, and twelve-month follow-up. At baseline, the item was “Have 
you ever been told by a doctor or other health care professional that you had an STD? By STD 
we mean, for example, chlamydia, gonorrhea (also known as the clap), syphilis, herpes, genital 
warts, Hepatitis B, or HIV?” Response options were “no, never,” “yes, but not in the past 3 
months,” and “yes, in the past 3 months.” On the four-month and twelve-month surveys, the item 
was modified to specify, “In the past 3 months, have you been told...” instead of “Have you ever 
been told…” Response options for these timepoints were “no, not in the past 3 months” and “yes, 
in the past 3 months.” Endorsements of “yes, in the past 3 months” were coded as positive for 
recent STI diagnosis. Endorsement of “yes, but not in the past 3 months” at baseline was coded 
as positive for lifetime STI diagnosis. 
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 Medical record data were abstracted by research staff into a structured database created 
by the investigators. For every visit in the medical record, research staff were prompted to report 
reasons for visit and pregnancy and STI testing and diagnosis. Current pregnancy was identified 
if one of the following criteria were met: 1) reason for visit was prenatal care or abortion; 2) 
pregnancy test was not taken because patient is currently pregnancy; or 3) outcome of pregnancy 
test was positive. Medical record data on pregnancy in the year prior to study enrollment 
matched the referent time period at baseline for pregnancy (past-year); pregnancy diagnoses 
were censored at the twelve-month survey to match that survey time period (past-year).  
For every visit abstracted, research assistants noted if there was an STI test done, whether 
an STI was diagnosed, and if so, which STI. A diagnosis of STI was coded as positive for STI 
diagnosis regardless of which STI was identified. To match the referent time periods of the 
surveys, recent IPV, RC, and STI were only counted in the medical record if the visit was within 
the three months prior to a survey but excluding the date of survey. This method was chosen 
because the participants took surveys prior to clinical visits and thus would not know their 
medical status (i.e., if an STI was diagnosed that day, the woman would not know at the time of 
the survey).  
7.3.3 Analysis 
Descriptive characteristics were obtained from the baseline surveys and reported. STI and 
pregnancy incidence were reported for each time point (baseline, four-month follow-up, and 
twelve-month follow-up, excluding past-year pregnancy at the four-month follow-up). Cohen’s 
kappa statistic for measuring agreement was calculated for each time point as well as pooled 
across all time points (accounting for clinic-level clustering). 
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  The agreement between self-report and medical record data was categorized for each 
health outcome as 1) no by self-report / not in medical record; 2) no by self-report / yes in 
medical record; 3) yes by self-report / not in medical record; and 4) yes by self-report / yes in 
medical record. To determine predictors of discordance for recent STI and past-year pregnancy, 
categorization was reported by variables of interest. Multinomial mixed models were used with 
the “concordant no” group serving as the reference category. Variables that were tested as 
predictors were age cohort (adolescent versus young adult), race/ethnicity, IPV, RC, and, for 
past-year pregnancy, pregnancy intention at baseline. All predictors were identified from the 
self-reported surveys. Models adjusted for age, race/ethnicity (where appropriate), intervention 
arm, and accounted for within-clinic clustering. SAS v9.496 was used for analyses and 
significance was set at α=0.05. 
7.4  RESULTS 
In this sample, 38.4% of the women were 16-19 years of age and 61.6% were 20-24 years of age; 
they were primarily non-Hispanic White (79.2%) (Table 13). One in four (23.4%) women had 
not completed a high school degree at the time of the baseline survey and one of every three 
women was single (31.5%).  
STI and pregnancy prevalence were both higher with self-report compared to medical 
record data (Table 14). Past 3 month STI were self-reported by 3.6-6.3% of participants across 
the three surveys while medical records indicated recent diagnoses in 1.2-2.0% of participants. 
Between baseline and T3 surveys, past year pregnancies were self-reported by 14.0-16.5% of 
participants and recorded in chart data for 6.6%-9.3% of participants.  
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The vast majority of observations (up to three per person) (94.6%) did not have an STI 
report via self-report or through the medical record data, with the remaining having an STI 
identified through at least one source. Of those occasions with at least one report of an STI (self-
report, medical record, or both; n=274 observations), two-thirds (68.6%) had self-reported STI 
that was not identified in the medical records. The remaining observations were identified as 
having an STI in both self-report and medical records (21.9%) or medical records but not self-
report (9.5%). Kappa statistics for the agreement between self-report and medical record data 
were similar across timepoints and had an overall agreement of Κ=0.343. 
Most observations (up to two per person) (84.0%) did not have a pregnancy recorded 
through self-report or medical records (Figure 1). Of those occasions with at least one pregnancy 
report (n=612 observations) 51.8% had pregnancy reports through self-report only and 42.0% 
had pregnancy reports through both self-report and medical records. The remaining observations 
(6.2%) had pregnancy reporting through medical records only. The Kappa statistics for the 
agreement between self-report and medical record data were similar between baseline and the 
twelve-month follow-up, with an overall agreement of Κ=0.545. 
A greater proportion of African-American women had discordant reporting of STI and 
pregnancy for both no by self-report / yes in medical record and yes by self-report / no in 
medical record, compared to their White and Multiracial/Other peers (Table 15). More women 
who experienced IPV or RC self-reported pregnancy that both were and were not documented in 
their medical records compared to women who did not experience IPV or RC, respectively. 
Experiencing RC was also associated with greater self-reporting of STI compared to women who 
did experience RC. Compared to adolescents, more young adult women self-reported 
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pregnancies that were not identified in their medical records. Conversely, more adolescents than 
young adults self-reported pregnancies that were substantiated in their medical records.  
Women who intended pregnancy at baseline were more likely to self-report pregnancies 
that were not found in the medical records at follow-up compared to women who did not intend 
pregnancy at baseline.  
Multinomial models were used to determine significant predictors of discordance after 
adjusting for age cohort, race/ethnicity, and intervention status (Table 16). Black women had 
higher odds of discrepant reporting for STI in both directions (AOR=5.68, 95% CI 2.82-11.4 for 
no by self-report / yes in medical record and AOR=3.01 [2.01-4.50] for yes by self-report / not in 
medical record). Reporting STI that were not in the medical records was also associated with 
recent IPV (AOR=1.82 [1.16-2.87]) and RC (AOR=2.82[1.74-4.59]). Similar results were found 
for pregnancy reporting. African-American women had higher odds of self-reporting STI that 
were not in their medical records compared to White women (AOR=1.84 [1.22-2.77]). Recent 
IPV (AOR=1.85 [1.39-2.46]) and recent RC (AOR=2.22 [1.57-3.13]) were also associated with 
higher odds of being categorized as yes by self-report / not in medical records. Women who 
reported at baseline that they were intending to become pregnant in the next year had higher odds 
of reporting a pregnancy that was not in the medical records (AOR=2.10 [1.37-3.21]).  
7.5  DISCUSSION 
This study demonstrates that partner violence – specifically intimate partner violence and 
reproductive coercion – is associated with discrepant reporting of sexual health outcomes among 
adolescent and young adult women attending family planning clinics when comparing their self-
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report of these indicators on a survey to their medical records. In this particular population, more 
cases of STI and pregnancy were identified through participants answering confidential surveys 
compared to data that were abstracted from the participants’ medical records. In general, 
agreement between these two data sources was poor.  
The reporting patterns found in this study are a stark contrast to most prior work. In one 
study, 4% of participants reported STI diagnoses in the absence of medical record 
documentation, while 40% of participants reported no STI despite the diagnosis in their medical 
records.76 Similarly, another study found accurate self-reporting in almost all (98.5-99.8%) of 
negative tests, but much lower accuracy for positive test results (56.5-74.6%).75 In contrast, 
however, it a study of pregnant women that found that recent and lifetime histories of STI 
diagnosis were significantly more likely to be identified via personal interviews compared to 
medical record data.155 In general, however, sexual behaviors that are socially sensitive (e.g., age 
at first sex, transactional sex) or socially rewarded (e.g., consistent condom use) – are more 
likely to be reported differentially by data collection instrument.156-158  
As the age range is similar to the other studies, it remains unclear why this study has the 
opposite pattern to most of the research to date. It is possible that the strong study design in this 
current project, which utilized confidential, self-administered surveys on three separate occasions 
(thus limiting the recall period), facilitated better self-reporting compared to previous studies.  In 
fact, reviews of the methodological challenges and validity of self-reported risk behaviors have 
stressed the importance of using short recall periods to facilitate more accurate reporting.159,160 
Furthermore, studies have found significant differences in the information self-reported based on 
the method by which the survey is conducted, such as interviewer-administered, self-
administered (“paper-and-pencil” surveys), or computer administered (with or without the use of 
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audio recordings of the questions)156,159 and self-reports over time.77,78 For example, socially 
sensitive questions such as initiation of sex, STI history, same-sex contact, are more likely to be 
reported on self- or computer-administered surveys compared to an interviewer.156-159  
Adolescents (16-19 years) in the present study were less likely to have discordant 
reporting compared to young adults (20-24 years), specifically for self-reporting an STI that was 
not confirmed in the medical record. While previous work has indicated that younger age is 
associated with inconsistent self-reporting over multiple time points,77,142,143 the present 
discrepancy may be due to using family planning clinic patients for the current study. It is 
possible that the older women had greater access to alternative healthcare providers compared to 
the adolescents, and thus were less likely to have the diagnosed STI documented in their medical 
records.  
A second demographic factor that was associated with discordant reporting was race. In 
particular, not only did African-American women have the highest prevalence of recent STI 
across the two reporting modalities, as is consistent with national estimates,140 they also had 
significantly (and dramatically) higher odds of discordance in that STI reporting. This is 
consistent with prior work that indicates African-American females report sexual behaviors less 
consistently over time compared to their White peers.142,143 However, the research to date does 
not explain the mechanisms by which these greater discordances occur. Women who reported an 
STI that was not substantiated in the medical record data may be due to their reporting 
gynecological conditions that are not actually STI, such as bacterial vaginosis. Bacterial 
vaginosis is more prevalent among African-American women161-163; incorrectly endorsing this as 
an STI may explain why African-American women had higher odds of self-reporting an STI that 
was not in the medical record, compared to White women. Additionally, African-American 
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women in this study were more likely to report that they received care in an emergency 
department in the past year during the twelve-month follow-up survey and less likely to have a 
primary care physician (data not shown); any STI diagnosed in the emergency department or 
other walk-in clinic would not have been entered into the patient’s medical record at the family 
planning clinic. However, this does not explain the increased odds of not self-reporting an STI 
that was documented in the medical record data. One possibility is that providing socially 
desirable information varied by race in this study (as it varied by age in a previous study9), but 
that is beyond the scope of the current data. 
Partner violence and reproductive coercion were also associated with discordant 
reporting. Women who experienced recent IPV or RC were significantly more likely to self-
report STI and pregnancies that were not documented in the medical records. Studies on partner 
influence of care seeking behaviors in the context of IPV/RC suggest that partners may interfere 
with getting consistent and required care.8 Therefore, it is possible that women are seeking care 
in other health settings and thus the STI and pregnancies are not captured in the family planning 
clinic data. This is supported in the present study, as women who self-reported recent IPV or RC 
at the twelve-month follow-up survey were more likely to report going to a primary care 
physician and emergency room for care in the past year (data not shown). Additionally, as 
abortions are also more prevalent among women experiencing abuse,164 it may be that, at least 
for pregnancy, that they are using home pregnancy tests and seeking pregnancy termination 
services elsewhere. Given this, research studies that rely on medical record data from a single 
healthcare center would underestimate the associations between IPV/RC and STI/pregnancy. 
However, it should be noted that the present study relied upon self-report only for IPV and RC, 
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as these data were too scarce in the medical records (<1%).  Medical records with more complete 
information on partner violence may lead to different conclusions.  
This study has several strengths to note. The longitudinal design allowed for survey data 
collection at three different times over a one year span; using the survey dates, we were able to 
restrict the medical record data to the periods of interest (past three months for STI, past year for 
pregnancy). This is especially important as a previous study found that among adolescent and 
young men that have ever self-reported an STI, the vast majority (94-98%) later denied any 
history of STI.78 Therefore, our longitudinal design allowed us to limit the likelihood of recall 
bias. The use of self-administered surveys on a computer allowed for participants to answer 
questions privately instead of directly to a person; this decreases the chances of social 
desirability bias in reporting STI and pregnancies. The vast majority of participants (97%) signed 
waivers for the research team to abstract medical record information, thus selection bias based on 
willingness to have the medical record reviewed is limited in this study.  
There are also several limitations. This present analysis excluded women who did not 
have sex with men or were not sexually active in the past three months, due to the survey design. 
Our conclusions are therefore not necessarily generalizable to sexual minority women or women 
who have not recently had sex. There were two main organizations that operated the family 
planning clinics, and the medical waivers participants signed were specific to the larger 
organization running the clinic where they received care. Thus, women who moved from one 
family planning agency to the other or into private care would have incomplete medical record 
information for the purposes of this study.  The parent study was a randomized controlled trial to 
test the effectiveness of a provider-delivered intervention to reduce the impacts of IPV and RC; 
while intervention status was controlled for in the multinomial models and was not a significant 
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predictor of STI or pregnancy category in models adjusted for age cohort and race/ethnicity (STI 
model, p=0.38 and pregnancy model, p=0.45), we cannot rule out residual confounding.  
 Given the higher prevalence of STI and pregnancy found with self-report compared to 
medical record data, it may be advantageous to focus research efforts on optimizing study survey 
design, such as by more frequent follow-up assessments to allow for shorter time periods of 
recall, instead of abstracting medical record data. In this study, the abstracted data identified 
≤1% of STI and pregnancy cases that were not reported by participants on the surveys; thus, the 
value of this additional data abstraction step is negligible. This study assessed predictors of 
discordant reporting of sexual health outcomes among adolescent and young adult women 
patients of family planning clinics, with race and partner violence emerging as important 
determinants. Research on adolescent and young adult sexual health, which already has an 
increasing focus on the importance of race and partner factors, should consider these findings in 
determining best study designs, data collection methods, and outcome ascertainment. 
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7.6  TABLES AND FIGURES 
Table 13. Participant characteristics self-reported at baseline 
Characteristic Total 
(n =2,203) 
% (n)a 
Age  
   16-17 years 13.6 (300) 
   18-19 years 24.8 (547) 
   20-22 years 41.4 (911) 
   23-24 years 20.2 (445) 
Race/ethnicity  
   Black/African-American     14.1 (310) 
   White 79.2 (1,745) 
   Multiracial or Other 6.2 (137) 
Highest education level completed  
   Less than high school degree 23.4 (515) 
   High school degree / GED 28.6 (629) 
   Some college 34.6 (763) 
    Finished college or graduate school 12.9 (285) 
Relationship status  
   Single/dating more than one person 31.5 (693) 
   Dating one person/In a serious relationship 63.4 (1,396) 
     Married 4.3 (94) 
a Percentages may not sum to 100 due to small amounts of missing date and rounding 
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Table 14. STI and pregnancy prevalence by data source and time point 
Outcome Baseline Four-month 
follow-up 
Twelve-month 
follow-up 
Any event across all 
timepoints  
 Self-report Medical 
record 
Self-report Medical 
record 
Self-report Medical 
record 
Self-report Medical 
record 
 n=2,203 n=2,203 n=1,212 n=1,212 n=1,613 n=1,613 n=5,028 n=5,028 
Recent STI, % (n) 5.2 (114) 2.0 (43) 6.3 (76) 1.9 (23) 3.6 (58) 1.2 (20) 4.9 (248) 1.7 (86) 
 n=2,203 n=2,203   n=1,613 n=1,613 n=3,816 n=3,816 
Past-year 
pregnancy, % (n) 
14.0 (308) 6.6 (145) --- --- 16.5 (266) 9.3 (150) 15.0 (574) 7.7 (295) 
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Table 15. Associations with discordant reporting 
 No by self-report Yes by self-report 
 Not in medical 
record 
% (n)a 
Yes in medical 
record 
% (n)a 
Not in medical 
record 
% (n)a 
Yes in medical 
record 
% (n)a 
 Recent STI 
Sample size n=4754b n=26b n=188b n=60b 
Total 94.6 (4754) 0.5 (26) 3.7 (188) 1.2 (60) 
Cohen’s Κ (95% CI)c 0.343 (0.246-0.439) 
Age group     
   Adolescents (16-19 
years) 
94.1 (1837) 0.8 (15) 3.6 (70) 1.6 (31) 
   Young adults (20-24 
years) 
94.9 (2917) 0.4 (11) 3.8 (118) 0.9 (29) 
   χ2 p-valued    0.185 
Race/ethnicity     
   White 95.8 (3838) 0.3 (13) 2.9 (116) 1.0 (41) 
   Black/African-American 88.4 (625) 1.7 (12) 8.4 (59) 1.6 (11) 
   Multiracial or Other 93.0 (291) 0.3 (1) 4.2 (13) 2.6 (8) 
   χ2 p-valued    0.003 
Intimate partner violence     
   Yes 91.1 (0.6) 0.6 (3) 6.1 (32) 2.3 (12) 
   No 95.0 (4274) 0.5 (23) 3.5 (156) 1.1 (48) 
   χ2 p-valued    0.105 
Reproductive coercion     
   Yes 85.5 (200) 0 (0) 10.7 (25) 3.9 (9) 
   No 95.0 (4554) 0.5 (26) 3.4 (163) 1.1 (51) 
   Fisher exact p-valuee    <.0001 
 Past-year pregnancy 
Sample size n=3204f n=38f n=317f n=257f 
Total 84.0 (3204) 1.0 (38) 8.3 (317) 6.7 (257) 
Cohen’s Κ (95% CI)c 0.545 (0.417-0.674) 
Age group     
   Adolescents (16-19 
years) 
85.9 (1256) 1.3 (19) 6.4 (94) 6.4 (94) 
   Young adults (20-24 
years) 
82.8 (1948) 0.8 (19) 9.5 (223) 6.9 (163) 
   χ2 p-valued    0.027 
Race/ethnicity     
   White 85.3 (2617) 1.0 (29) 7.2 (220) 6.6 (201) 
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   Black/African-American 75.9 (388) 1.6 (8) 13.9 (71) 8.6 (44) 
   Multiracial or Other 83.6 (199) 0.4 (1) 10.9 (26) 5.0 (12) 
   χ2 p-valued    0.153 
Intimate partner violence     
   Yes 81.2 (315) 1.3 (5) 13.1 (51) 4.4 (17) 
   No 84.3 (2889) 1.0 (33) 7.8 (266) 7.0 (240) 
   χ2 p-valued    0.004 
Reproductive coercion     
   Yes 73.1 (136) 0.5 (1) 17.7 (33) 8.6 (16) 
   No 84.5 (3068) 1.0 (37) 7.8 (284) 6.6 (241) 
   χ2 p-valued    <.001 
 n=1,2055 n=145 n=1275 n=1305 
Pregnancy intention     
   Intended 68.4 (39) 0 (0) 19.3 (11) 12.3 (7) 
   Not intended 82.2 (1,166) 1.0 (14) 8.2 (116) 8.7 (123) 
   Fisher exact p-valuee    0.026 
a Row percent 
b Sample size is based on 2,203 unique baseline participants with up to two (pregnancy) or three 
(STI) total observations 
c Κ statistic did not significantly vary by timepoint so is presented as a pooled value, accounting 
for clinic-level clustering   
d P-value calculated using a Wald log-linear χ2 test for overall difference between predictor and 
STI/pregnancy reporting group and accounting for within-clinic clustering 
e P-value calculated using a Fisher’s exact test (due to small cell size) to test for overall 
difference between predictor and STI/pregnancy reporting group 
f Sample size is based on 1,476 participants who completed baseline pregnancy intention items 
and the T3 survey 
Table 15 Continued 
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Table 16. Multinomial logistic regression models to test the association between proposed predictors and STI / pregnancy reporting 
status 
Predictors of discordant 
reporting 
No by self-report / yes in 
medical record 
AOR (95% CI)a 
Yes by self-report / not in 
medical record  
AOR (95% CI)a 
Yes by self-report / yes in 
medical record  
AOR (95% CI)1 
 Recent STI 
Age cohortb    
   Adolescents (16-19 years) 1.86 (0.81-4.31) 0.91 (0.67-1.23) 1.64 (0.98-2.75) 
   Young adults (20-24 years) -Reference Group- -Reference Group- -Reference Group- 
Race/ethnicityc    
   White -Reference Group- -Reference Group- -Reference Group- 
   Black/African American 5.68 (2.82-11.4) 3.01 (2.01-4.50) 1.61 (0.89-2.90) 
   Multiracial or Other 0.93 (0.19-4.58) 1.49 (0.80-2.77) 2.49 (0.94-6.55) 
Intimate partner violenced    
   Yes 1.01 (0.38-2.70) 1.82 (1.16-2.87) 2.01 (0.90-4.47) 
   No -Reference Group- -Reference Group- -Reference Group- 
Reproductive coerciond    
   Yes N/A 2.82 (1.74-4.59) 3.46 (1.69-7.08) 
   No -Reference Group- -Reference Group- -Reference Group- 
 Past-year pregnancy 
Age cohortb    
   Adolescents (16-19 years) 1.59 (0.81-3.12) 0.63 (0.50-0.80) 1.00 (0.80-1.25) 
   Young adults (20-24 years) -Reference Group- -Reference Group- -Reference Group- 
Race/ethnicityc    
   White -Reference Group- -Reference Group- -Reference Group- 
   Black/African American 1.22 (0.50-3.01) 1.84 (1.22-2.77) 0.93 (0.49-1.79) 
   Multiracial or Other 0.36 (0.05-2.47) 1.57 (0.89-2.79) 0.65 (0.37-1.15) 
Intimate partner violenced    
   Yes 1.27 (0.63-2.56) 1.85 (1.39-2.46) 0.69 (0.39-1.21) 
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   No -Reference Group- -Reference Group- -Reference Group- 
Reproductive coerciond    
   Yes 0.50 (0.12-2.04) 2.22 (1.57-3.13) 1.43 (0.74-2.78) 
   No -Reference Group- -Reference Group- -Reference Group- 
Next-year pregnancy intention    
    Intended N/A 2.10 (1.37-3.21) 1.17 (0.50-2.76) 
    Not intended -Reference Group- -Reference Group- -Reference Group- 
a Reference group is no by self-report / not in medical record 
b Model adjusted for race/ethnicity and intervention status 
c Model adjusted for age cohort and intervention status 
d Model adjusted for age cohort, race/ethnicity, and intervention status 
N/A: not applicable, as category had no responses or too few responses to estimate effects 
Table 16 Continued 
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Baseline: n=3,687 
Four-month 
follow-up: n=3,017 
Twelve-month follow-
up: n=2,926 
>24 years: 
n=990 
No sex with 
men: 
n=125 
No recent 
sex: 
n=209 
Missing key 
measures: 
n=99 
No medical 
record data: 
n=61 
Total included: 
n=2,203 
>24 years: 
n=837 
No sex with 
men: 
n=99 
No recent 
sex: 
n=752 
Missing key 
measures: 
n=100 
No medical 
record data: 
n=17 
>24 years: 
n=823 
No sex with 
men: 
n=82 
No recent 
sex: 
n=210 
Missing key 
measures: 
n=162 
No medical 
record data: 
n=198 
Total included: 
n=1,121 
Total included: 
n=1,613 
Figure 2. Study flow diagram for analytic sample 
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8. SYNTHESIS 
8.1  OVERVIEW OF RESEARCH FINDINGS 
This dissertation used data from a clinical trial conducted among family planning clinic patients 
as well as nationally representative survey data to study the relationship between partner 
influence, including intimate partner violence and reproductive coercion, on adolescent and 
young adult women’s reproductive and sexual health.  
Aim 1 assessed condom negotiation self-efficacy as a mediator in the relationship 
between IPV/RC and unintended pregnancy/STI. Given the high rates of poor sexual health 
outcomes among women experiencing IPV, identifying a key mechanism on this pathway has the 
potential to impact a large portion of the female population. We found that recent experiences of 
IPV or RC were associated with decreased condom negotiation self-efficacy, increased 
unintended pregnancy, and increased STI. However, the impact of IPV and RC on condom 
negotiation self-efficacy largely did not mediate the relationships between IPV/RC and 
unintended pregnancy/STI. Thus, while sexual self-efficacy is modifiable through intervention,94-
96 this focus alone would not be sufficient to reduce unintended pregnancy or STI incidence. 
Programs should go beyond increasing condom negotiation skills of adolescent and young adult 
women.  
Aim 2 assessed adolescent and young adult women’s use of female-controlled 
contraceptives (FCC) and male partners’ influence on use of these methods. FCC (including oral 
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contraception, intrauterine devices, implants, injectables, patches, and rings) are more effective 
at preventing pregnancy than condoms alone or other methods such as withdrawal or rhythm 
planning.116 While there are varying degrees of a woman’s control for the various FCC methods, 
they can be used without a male partner’s knowledge or cooperation if needed or desired. We 
found that roughly half of women 15-24 years are using an FCC method, but the majority of 
these are oral contraception users. Use of longer acting reversible contraceptives, which are 
extremely effective at preventing pregnancy116 are used by only a small minority of young 
women.   
Male partner influence, defined in Aim 2 as a partner influencing past contraception 
termination, was associated with greater current use of FCC (young adult women only) and past-
year number of FCC methods (adolescent and young adults). This may indicate that women, 
especially those who are past adolescence, who have experienced this influence cope by trying 
various methods that offer them greater reproductive autonomy. Adolescents who experienced 
partner influence had lower current FCC use and more months of FCC nonuse. Adolescents, 
regardless of partner influence, reported more FCC methods and discontinuing more FCC 
methods in the past year compared to young adult women. Public health practitioners and 
clinicians should address contraceptive method choice and use in the context of partner 
influence. For example, by specifically talking to women about partner influences and addressing 
barriers that women face including partners’ interference and influence over contraceptive 
decision making, discussions around contraceptive choice can better support women’s autonomy,  
focus on methods that partners are least likely to interfere with, and provide women with a range 
of options. Adolescents in particular appear to need more assistance with coping to partner 
influence and finding contraception that is right for them. It is important to note here that male 
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partner influence did not include intimate partner violence or reproductive coercion, but rather 
more subtle behaviors. Thus, practitioners should be aware that contraceptive use among women 
who do not experience partner violence may also be impacted by past and current partners in a 
less overt (but still influential) manner. 
A secondary finding from this study (Aim 2) was that minority women have less optimal 
use of contraception compared to White women in the U.S. This is consistent with previous 
research of racial and ethnic differences in reproductive and sexual health. Further, differential 
healthcare access, utilization,137 knowledge, and attitudes,138 by race and ethnicity do not account 
for these disparities in previous work. Thus, there should be a continued push to ensure equitable 
contraceptive coverage with the ultimate goal being to end racial and ethnic disparities in 
unintended pregnancies34 and STI acquisition.165 
Aim 3 assessed the concordance between self-report and medical record data for 
pregnancies and STI to identify best practices for sexual health research, specifically in the 
context of partner violence. Young women who self-reported IPV or RC had significantly higher 
odds of self-reporting on a confidential survey a diagnosis of recent STI or past-year pregnancy 
compared to women who did not experience partner violence. Thus, relying on medical record 
data solely for sexual health outcomes in this study would have differentially underestimated the 
prevalence of STI and pregnancy among the abused women. Given that IPV and RC have been 
associated with STI (IPV only) and unintended pregnancies, studies that rely on the medical 
record data may have been underestimating even stronger associations than normally observed. 
This highlights the crucial need programs that help to alleviate the public health burden of these 
problems at multiple levels: first for partner violence, before it begins, identifying it earlier, and 
aiding with harm reduction strategies to minimize harmful consequences, and second, for STI 
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and unintended pregnancy, by educating adolescents on healthy relationships and ways to protect 
themselves (e.g., condoms, longer acting reversible contraception).   
It should be noted that in the medical record data of these family planning clinic patients, 
IPV and RC disclosure were rare (<10 cases in the eligible sample and time periods for Aim 3), 
precluding the comparison of this data to self-report and for the use of predicting concordance. 
This study is therefore limited by using only data self-reported by participants on surveys to 
assess concordance of data collected both by self-report on surveys and documentation in the 
medical record.  
Overall, taken together, these three studies aimed to determine key factors in the 
pathways, patterns, and assessment of negative male partner influences on young women’s 
reproductive/sexual health and contraceptive use. This project demonstrated that adolescent and 
young adult women, who are at different developmental stages of their lives, are too dissimilar to 
assess as one larger group; in particular, partner violence and other sources of partner influence 
appear to differentially impact their sexual and reproductive health. Additionally, what was 
assessed at presumably more “subtle” levels of partner influence appeared to be related to young 
women’s recent contraceptive use. Studies that are longitudinal, utilize self-report on 
confidential surveys to ensure privacy, and limit recall periods appear to provide higher 
prevalence estimates for STI and pregnancy.  
8.2  STRENGTHS AND LIMITATIONS OF THIS RESEARCH 
There are a number of considerable strengths in this research. Aims 1 and 3 were addressed 
using longitudinal data, with three survey time points and up to 30 months of medical record 
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data. This allowed for key measures, including IPV, RC, STI, and unintended pregnancy to be 
assessed multiple times, and where appropriate, be time-varying in models. The relatively high-
risk population (family planning clinic patients) used for Aims 1 and 3 was balanced by using a 
nationally representative sample for Aim 2. This provided a more nuanced and complete view of 
how males can influence their female partners. The ARCHES study (Aims 1 and 3) was 
conducted in a primarily rural setting, adding to the literature that is predominantly urban-based 
studies. Finally, Aim 2 was addressed using extensive data on contraceptive use, providing a 
month-by-month picture of how women in the U.S. are using contraception over a one-year 
period.   
 There are limitations to this research that should be noted. While the rural setting 
indicated in the ARCHES study is a strength, it does mean that the findings in Aims 1 and 3 may 
not generalize to other more urban and racially diverse populations. Contraceptive data used in 
Aim 2 was self-reported at one time point and not verified with outside sources (e.g., medical 
records, prescriptions). In addition, the partner influence determinants identified in Aim 2 were  
not asked of each person, but rather were contingent on certain conditions (e.g., a woman was 
only asked about her partner’s pregnancy intentions if they were married or living together).  
8.3 PUBLIC HEALTH SIGNIFICANCE 
Intimate partner violence (IPV) and reproductive coercion (RC) are serious, high-burden public 
health problems. In the U.S., it is estimated that 7 million women are victims of IPV each year 
and over 10 million women experience partners’ attempts to control their reproductive choices in 
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their lifetimes.4 These experiences are associated with unintended pregnancy, STI, and other 
poor reproductive and sexual health outcomes. 
In 2008, almost 3.4 million pregnancies in the United States were unintended, 
representing half (51%) of all pregnancies; 15-19 and 20-24 year olds contributed 612,000 and 
1.1 million unintended pregnancies, respectively, to this count.34 Over one million reported cases 
of chlamydia occurred among individuals younger than 25 years of age in 2012 alone and 
women 15-24 years made up 35% of all cases of gonorrhea reported.99 Chlamydia and gonorrhea 
have been associated with one-third to one-half of all cases of pelvic inflammatory disease, 
which in turn is associated with long-term reproductive consequences, including infertility, 
chronic pelvic pain, and ectopic pregnancy.46 Thus, IPV, unintended pregnancies, and STI 
represent substantial, overlapping problems that have a profound impact on the health of 
adolescents and young adults. Innovative strategies to address this nexus of public health 
problems are needed.  
Findings from this dissertation can help to inform these desperately needed strategies to 
protect the health of these young women, establishing the public health significance of this work. 
Increasing self-efficacy (a common goal of sexual health interventions) is not sufficient for 
reducing the impact of partner violence of reproductive health outcomes and that many young 
women have already experienced STI and unintended pregnancy prior to introduction to such 
programs. Thus, not only should translational work identify a wider range of skills to address 
(e.g., condom use skills may be helpful beyond the self-efficacy to request condom usage), but it 
should also target women prior to these first adverse health outcomes, ideally before sexual 
debut. Additionally, a substantial proportion of sexually active women in the U.S. are not using 
adequate contraception, which is partially related to partner influence. At the population level, it 
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is crucial to increase use of highly effective contraception – particularly longer-acting reversible 
contraceptives. Finally, study design concerns were identified for public health research, which 
will help to improve the conduct of future research. 
8.4 DIRECTIONS FOR FUTURE RESEARCH 
This dissertation has opened up several promising avenues for future research. While recent 
IPV/RC and condom negotiation self-efficacy were associated with unintended pregnancy and 
STI, effects were relatively small when compared to the effects of previous experiences of STI 
and unintended pregnancies. Therefore, future research should focus on targeting younger 
adolescents who have not yet had these sexual health outcomes; ideally, interventions would 
occur prior to the adolescents initiating sex. Additionally, as we know that experiencing partner 
violence is associated with lower sexual self-efficacy, as shown in Aim 1, and that self-efficacy 
is modifiable,94-96 specific strategies to increase sexual self-efficacy and condom negotiation 
skills among women experiencing abuse should be explored. Future research should also identify 
the barriers to contraceptive use among women who have never used female-controlled 
contraception (versus consistent or intermittent users), as Aim 2 demonstrated that a substantial 
proportion of adolescent and young adult women had not used any female-controlled 
contraception in the past year. Additionally, the findings suggested that adolescents are 
particularly less adept at coping with partner influence compared to young adult women, and 
thus harm reductions strategies should be specifically identified and tailored to these girls.   
Finally, Aim 3 identified shortcomings specifically for research methodology. Findings 
indicate that study design is crucial, given the sensitive nature of this research.  Studies on 
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partner violence and sexual health should consider using longitudinal designs, have participants 
self-report on confidential, computer-administered surveys for greatest privacy, and have short 
recall periods. With this design, it appears that medical record data, at least when limited to one 
healthcare organization (such as a family planning clinic system), does not contribute 
meaningfully to prevalence estimates (≤1%) and rarely provided information on IPV and RC 
disclosures. Further, as women who are higher risk for STI and pregnancy also were significantly 
more likely to self-report STI and pregnancies that were not found in the medical record data 
(women experiencing IPV or RC, older, or African-American), medical record data alone would 
differentially underestimate their true disease burden. Thus, greater equity in research may be 
achieved through optimizing conditions for accurate self-reporting. 
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APPENDIX: KEY MEASURES FROM THE ADDRESSING REPRODUCTIVE COERCION IN HEALTH SETTINGS 
STUDY 
Table 17. Survey items from the ARCHES study 
Survey 
Response Options Baseline T2 T3 
Intimate Partner Violence: “In the past three months…” 
… have you been hit, pushed, slapped, choked, or otherwise physically hurt by
someone you were dating or going out with? 
Yes / No X X X 
… has someone you were dating or going out with used force or threats to
make you have sex (vaginal, oral, or anal sex) when you didn't want to? 
Yes / No X X X 
… has someone you were dating or going out with made you have sex
(vaginal, oral, or anal sex) when you didn't want to, but didn't use force or 
threats? 
Yes / No X X X 
Reproductive Coercion: “In the past three months, has someone you were 
dating or going out with…” 
…tried to force or pressure you to become pregnant? Yes / No X X X 
…told you not to use any birth control (like the pill, shot, ring, etc)? Yes / No X X X 
…said he would leave you if you didn't get pregnant? Yes / No X X X 
…told you he would have a baby with someone else if you didn't get pregnant? Yes / No X X X 
…taken off the condom while you were having sex, so you would get
pregnant? 
Yes / No X X X 
…put holes in the condom so you would get pregnant? Yes / No X X X 
…broken the condom on purpose while you were having sex so you would get
pregnant? 
Yes / No X X X 
…taken your birth control (like pills) away from you or kept you from going to
the clinic to get birth control? 
Yes / No X X X 
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 …made you have sex without a condom so you would get pregnant? Yes / No X X X 
 …hurt you physically because you did not agree to get pregnant? Yes / No X X X 
Condom Negotiation Self-Efficacy     
 I feel confident in my ability to discuss condom use with any partner I might 
have. 
5 point Likert scale, 
Strongly agree to 
Strongly disagree 
X X X 
 I feel confident in my ability to suggest using condoms with a new partner. 5 point Likert scale, 
Strongly agree to 
Strongly disagree 
X X X 
 If I were to ask my partner to use a condom, I would be afraid that my partner 
would be upset with me. 
5 point Likert scale, 
Strongly agree to 
Strongly disagree 
X X X 
 If I were unsure of my partner's feelings about using condoms, I would not ask 
my partner to use one. 
5 point Likert scale, 
Strongly agree to 
Strongly disagree 
X X X 
 If my partner didn't want to use a condom during sex, I feel confident in my 
ability to refuse to have sex. 
5 point Likert scale, 
Strongly agree to 
Strongly disagree 
X X X 
STI History     
 Have you ever been told by a doctor or other health care professional that you 
had an STD? By STD we mean, for example, Chlamydia, honorrhea (also 
known as the clap), syphillis, herpes, genital warts, Hepatitis B, or HIV? 
No, never 
Yes, but not in the past 
3 months 
Yes, in the past 3 
months 
X   
 In the past 3 months, have you been told by a doctor or other health care 
professional that you had an STD? By STD we mean, for example, Chlamydia, 
gonorrhea (also known as the clap), syphilis, herpes, genital warts, Hepatitis B, 
or HIV? 
No, not in the past 3 
months 
Yes, in the past 3 
months 
 X X 
     
     
Pregnancy History     
 How many times have you been pregnant when you didn't want to be? None, this has never 
happened to me 
Once 
Twice or more 
X   
Table 17 Continued 
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 How many times have you been pregnant in the past 12 months? I have not been 
pregnant in the past 12 
months 
Once 
Twice or more 
X  X 
 Would you say this most recent pregnancy came too soon, at the right time, or 
later than you wanted? 
Too soon 
Right time 
Later than I wanted 
  X 
 Right before you became pregnant most recently, did you plan to get pregnant? Yes / No   X 
 In the month before this most recent pregnancy, would you say that you 
wanted to have a baby with your partner at the time? 
Yes / No   X 
 If you had to rate from 0 to 4 how much you wanted or did not want a 
pregnancy right before this most recent pregnancy, how would you have rated 
yourself? 
5 point Likert scale, 
Wanted to avoid to 
wanted to get pregnant 
  X 
 Right before you became pregnant with your most recent pregnancy, how 
much were you trying to get pregnant? 
5 point Likert scale, 
Trying not to get 
pregnant to really 
trying hard to get 
pregnant 
  X 
 Right before you became pregnant with your most recent pregnancy, how 
much were you trying to avoid getting pregnant? 
5 point Likert scale, 
Not trying to avoid to 
trying to avoid 
  X 
 How happy did you feel when you found out you were pregnant? 5 point Likert scale, 
Very unhappy to very 
happy 
  X 
Table 17 Continued 
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